[
  {
    "claim_id": "Q45982518$F33CEA4F-A019-48F1-8978-7FCFB4043DCC",
    "theme": "ChemicalCompound",
    "subject_label": "Acute MDMA and ethanol interaction effects on psychomotor performance.",
    "subject_id": "Q45982518",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "4",
    "object_id": "",
    "context": "Acute MDMA and ethanol interaction effects on psychomotor performance. Issue 4.",
    "propertyCQ": "What is the number 4 of the effects of MDMA and ethanol on psychomotor performance?",
    "objectCQ": "What is the number of issues that affect psychomotor performance?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50630839$7FD1C940-2CBB-4615-B370-95D0D010ED6F",
    "theme": "ChemicalCompound",
    "subject_label": "The psychobiology of MDMA or 'ecstasy': symposium arranged by the Psychobiology Section, at the Annual Conference of the British Psychological Society, Heriot-Watt University, Edinburgh, April 1997.",
    "subject_id": "Q50630839",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "1",
    "object_id": "",
    "context": "The psychobiology of MDMA or 'ecstasy': symposium arranged by the Psychobiology Section, at the Annual Conference of the British Psychological Society, Heriot-Watt University, Edinburgh, April 1997. Issue 1 was published.",
    "propertyCQ": "What was the first issue of the symposium?",
    "objectCQ": "What was the title of the issue of the symposium?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q42455664$7157375C-7236-45C5-9CC2-1034238F4590",
    "theme": "ChemicalCompound",
    "subject_label": "3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors.",
    "subject_id": "Q42455664",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "8",
    "object_id": "",
    "context": "3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors. Issue 8:",
    "propertyCQ": "What is the number 8 of the causes of MDMA?",
    "objectCQ": "What is the number of issues with MDMA?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q57986566$66E99430-13C7-423A-9CF7-87AE61B73092",
    "theme": "ChemicalCompound",
    "subject_label": "An assessment of the stability of MDMA, methamphetamine and THC in oral fluid",
    "subject_id": "Q57986566",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "4",
    "object_id": "",
    "context": "An assessment of the stability of MDMA, methamphetamine and THC in oral fluid is issue 4.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44811433$A1C29F98-2878-4DA3-9785-3341F66381BC",
    "theme": "ChemicalCompound",
    "subject_label": "Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.",
    "subject_id": "Q44811433",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "7",
    "object_id": "",
    "context": "Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Issue 7.",
    "propertyCQ": "What is the number 7 of the consequences of MDMA and its enantiomers?",
    "objectCQ": "What is the number of issues that have been analyzed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q48608076$492DA6F5-F695-43BE-A425-CEE7B4567796",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats.",
    "subject_id": "Q48608076",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "3",
    "object_id": "",
    "context": "Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Issue 3.",
    "propertyCQ": "What is the number 3 of the study?",
    "objectCQ": "What is the number of issues?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44915720$44BA4E70-083F-4A68-9FDF-8762F6F065E7",
    "theme": "ChemicalCompound",
    "subject_label": "Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).",
    "subject_id": "Q44915720",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "3",
    "object_id": "",
    "context": "Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003). Issue 3.",
    "propertyCQ": "What is the third issue of Ecstasy in the UK?",
    "objectCQ": "What is the number of issues of Ecstasy in the UK?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40529624$15D6831C-11F6-4E2D-ACC2-B8BA941947C2",
    "theme": "ChemicalCompound",
    "subject_label": "Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.",
    "subject_id": "Q40529624",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "2",
    "object_id": "",
    "context": "Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Issue 2.",
    "propertyCQ": "What is issue 2 of the study?",
    "objectCQ": "What is the issue of MDMA?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44599215$163091E0-4FDB-4E87-9F87-6FED1AF211C0",
    "theme": "ChemicalCompound",
    "subject_label": "Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility.",
    "subject_id": "Q44599215",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "1",
    "object_id": "",
    "context": "The microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility. Issue 1.",
    "propertyCQ": "What is the first issue with MDMA?",
    "objectCQ": "What is the issue of MDMA in mice?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q33907331$1231AECC-9375-44DB-B94F-C4262E9EB428",
    "theme": "ChemicalCompound",
    "subject_label": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans.",
    "subject_id": "Q33907331",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "4",
    "object_id": "",
    "context": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans. Issue 4.",
    "propertyCQ": "What is the fourth issue of MDMA?",
    "objectCQ": "What is the number of issues that are related to MDMA?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q38220603$54664EEA-3C1E-4843-BFF6-AB5C14953C40",
    "theme": "ChemicalCompound",
    "subject_label": "Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases.",
    "subject_id": "Q38220603",
    "property_label": "issue",
    "property_id": "P433",
    "object_label": "8",
    "object_id": "",
    "context": "The issue 8 of Hallucinogen persisting perception disorder and the serotonergic system: a comprehensive review including new MDMA-related clinical cases.",
    "propertyCQ": "What is issue 8 of Hallucinogen persisting perception disorder?",
    "objectCQ": "What is the issue of Hallucinogen persisting perception disorder?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q212774$6E9084D1-70CF-4160-A542-2A9B316829A0",
    "theme": "ChemicalCompound",
    "subject_label": "α-D-xylopyranose",
    "subject_id": "Q212774",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "α-D-arabinopyranose",
    "object_id": "Q27120749",
    "context": "α-D-xylopyranose is a stereoisomer of α-D-arabinopyranose.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q76513171$408f516b-4669-04b3-8ac0-7db57e193707",
    "theme": "ChemicalCompound",
    "subject_label": "bradanicline",
    "subject_id": "Q76513171",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "N-[(2S,3S)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide",
    "object_id": "Q7669595",
    "context": "The stereoisomer of bradanicline is N-[(2S,3S)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide.",
    "propertyCQ": "",
    "objectCQ": "What is the stereoisomer of bradanicline?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27180466$0E00CBF0-FC95-4206-B80F-54BDE48E6C33",
    "theme": "ChemicalCompound",
    "subject_label": "1-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea",
    "subject_id": "Q27180466",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "1-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea",
    "object_id": "Q27180561",
    "context": "1-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-[[methyl(pyridin-4-ylmethyl)amino]methyl]-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea is",
    "propertyCQ": "What is the function of the methyl group?",
    "objectCQ": "What is the name of the compound that is used to describe it?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q212774$F6ACC0EF-559F-4250-ABFE-C6B5EC1D185E",
    "theme": "ChemicalCompound",
    "subject_label": "α-D-xylopyranose",
    "subject_id": "Q212774",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "β-L-arabinopyranose",
    "object_id": "Q27120409",
    "context": "α-D-xylopyranose is a stereoisomer of β-L-arabinopyranose.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q74417505$7408bd48-444e-4785-1526-362049377b3c",
    "theme": "ChemicalCompound",
    "subject_label": "β-L-arabinofuranose",
    "subject_id": "Q74417505",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "α-D-arabinofuanose",
    "object_id": "Q85552423",
    "context": "β-L-arabinofuranose is a stereoisomer of α-D-arabinofuanose.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27120759$d9c28f85-4529-dc10-b90b-3cde51763c52",
    "theme": "ChemicalCompound",
    "subject_label": "aldehydo-D-ribose",
    "subject_id": "Q27120759",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "aldehydo-L-xylose",
    "object_id": "Q27082478",
    "context": "Aldehydo-D-ribose is a stereoisomer of aldehydo-L-xylose.",
    "propertyCQ": "What is aldehydo-D-ribose?",
    "objectCQ": "Aldehydo-D-ribose is a stereoisomer of what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27092902$bf7eaf11-45e5-6064-b610-d63709ed6ef7",
    "theme": "ChemicalCompound",
    "subject_label": "L-allo-Isoleucine",
    "subject_id": "Q27092902",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "D-alloisoleucine",
    "object_id": "Q27109362",
    "context": "L-allo-Isoleucine is a stereoisomer of D-alloisoleucine.",
    "propertyCQ": "What is L-allo-Isoleucine?",
    "objectCQ": "What is L-allo-Isoleucine a stereoisomer of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q415007$0A6B6751-3779-40B1-ACCB-179615CF6113",
    "theme": "ChemicalCompound",
    "subject_label": "(+)-catechin",
    "subject_id": "Q415007",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "(+)-epicatechin",
    "object_id": "Q27145771",
    "context": "(+)-catechin is a stereoisomer of (+)-epicatechin.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q19903943$d2738b0d-4ad4-467f-26f9-3eb089c463c3",
    "theme": "ChemicalCompound",
    "subject_label": "desacetoxyvindoline",
    "subject_id": "Q19903943",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "deacetoxyvindoline",
    "object_id": "Q27102152",
    "context": "The stereoisomer of deacetoxyvindoline is deacetoxyvindoline.",
    "propertyCQ": "What is deacetoxyvindoline?",
    "objectCQ": "What is the stereoisomer of deacetoxyvindoline?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27104150$0511a022-4dc5-a486-4098-fb0bb72c80a2",
    "theme": "ChemicalCompound",
    "subject_label": "L-malic acid",
    "subject_id": "Q27104150",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "D-malic acid",
    "object_id": "Q27104149",
    "context": "L-malic acid is a stereoisomer of D-malic acid.",
    "propertyCQ": "What is L-malic acid?",
    "objectCQ": "What is L-malic acid a stereoisomer of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27120749$959FA93B-92A2-4834-A887-A6F373A4555E",
    "theme": "ChemicalCompound",
    "subject_label": "α-D-arabinopyranose",
    "subject_id": "Q27120749",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "α-L-xylopyranose",
    "object_id": "Q27461216",
    "context": "α-D-arabinopyranose is a stereoisomer of α-L-xylopyranose.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27093808$fececd2a-43d0-0771-02d4-14ecd2876b4b",
    "theme": "ChemicalCompound",
    "subject_label": "(R)-timonacic",
    "subject_id": "Q27093808",
    "property_label": "stereoisomer of",
    "property_id": "P3364",
    "object_label": "(S)-timonacic",
    "object_id": "Q27133347",
    "context": "The stereoisomer of (S)-timonacic is (R)-timonacic.",
    "propertyCQ": "",
    "objectCQ": "What is the stereoisomer of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$A0D413FA-495A-4D57-B04B-3B20AD1F6422",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "173",
    "object_id": "",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Volume 173.",
    "propertyCQ": "What is the name of the book that describes the effects of MDMA on dopamine biochemistry and function?",
    "objectCQ": "What is the volume of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50426792$F3EC6173-BA85-40AD-86A5-48CB6EF56EA2",
    "theme": "ChemicalCompound",
    "subject_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subject_id": "Q50426792",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "21",
    "object_id": "",
    "context": "The zebra mussel has 21 volumes and is the subject of environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity.",
    "propertyCQ": "How many volumes does the zebra mussel have?",
    "objectCQ": "How many volumes does the zebra mussel have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q47744785$9A240FD6-882D-4C9B-B15A-2D61C83EFCC5",
    "theme": "ChemicalCompound",
    "subject_label": "Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors.",
    "subject_id": "Q47744785",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "47",
    "object_id": "",
    "context": "Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors. Volume 47.",
    "propertyCQ": "What is the number of the volume of the study?",
    "objectCQ": "What is the volume of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44387904$2555C8C8-8EFB-47CF-9AB3-3B6B384B2657",
    "theme": "ChemicalCompound",
    "subject_label": "Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes.",
    "subject_id": "Q44387904",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "72",
    "object_id": "",
    "context": "Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes. Volume 72.",
    "propertyCQ": "What is the number of volumes of the study?",
    "objectCQ": "What is the volume of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46627187$E7A12EF1-6DA0-4916-A5D8-D49AC4DB83CD",
    "theme": "ChemicalCompound",
    "subject_label": "Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].",
    "subject_id": "Q46627187",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "81",
    "object_id": "",
    "context": "A chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]. The volume is 81.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46726341$606748F3-002B-41AF-9C3C-9BE7435C52E2",
    "theme": "ChemicalCompound",
    "subject_label": "Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.",
    "subject_id": "Q46726341",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "10",
    "object_id": "",
    "context": "The long-term effects of MDMA (Ecstasy) on the human central nervous system are revealed by visual evoked potentials. Volume 10.",
    "propertyCQ": "What is the number 10 of visual evoked potentials?",
    "objectCQ": "What is the volume of the visual evoked potentials?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q92808146$6D7EF6F6-F481-4658-BCEF-9FB4EFAE3711",
    "theme": "ChemicalCompound",
    "subject_label": "An investigation of the reinforcing effects of MDMA in rats trained to self-administer heroin",
    "subject_id": "Q92808146",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "99",
    "object_id": "",
    "context": "An investigation of the reinforcing effects of MDMA in rats trained to self-administer heroin has a volume of 99.",
    "propertyCQ": "What is the number of studies that have been done on rats trained to self-administer heroin?",
    "objectCQ": "What is the volume of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46862552$686C9350-FD6D-487E-866E-637355624429",
    "theme": "ChemicalCompound",
    "subject_label": "An analysis of spontaneous behavior following acute MDMA treatment in male and female rats.",
    "subject_id": "Q46862552",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "28",
    "object_id": "",
    "context": "An analysis of spontaneous behavior following acute MDMA treatment in male and female rats. Volume 28.",
    "propertyCQ": "What is the name of the volume 28?",
    "objectCQ": "What is the volume of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q33907331$F755F9F3-31E6-49EA-A78F-43EF8E6C7DE9",
    "theme": "ChemicalCompound",
    "subject_label": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans.",
    "subject_id": "Q33907331",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "10",
    "object_id": "",
    "context": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans. Volume 10.",
    "propertyCQ": "What is the name of the book that describes the effects of MDMA on the body?",
    "objectCQ": "What is the volume of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37149027$E2762EC9-9331-4699-B830-3D5A94B2B403",
    "theme": "ChemicalCompound",
    "subject_label": "MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology",
    "subject_id": "Q37149027",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "11",
    "object_id": "",
    "context": "MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology is published in volume 11.",
    "propertyCQ": "",
    "objectCQ": "What is the volume number of MDMA Analogues as Tools to Characterize MDMA-Like Effects?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q48166493$CB68A423-3712-4C66-B556-EF998BC3E342",
    "theme": "ChemicalCompound",
    "subject_label": "Novel object recognition memory: measurement issues and effects of MDMA self-administration following short inter-trial intervals.",
    "subject_id": "Q48166493",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "25",
    "object_id": "",
    "context": "Novel object recognition memory: measurement issues and effects of MDMA self-administration following short inter-trial intervals. Volume 25.",
    "propertyCQ": "What is the name of the book that discusses the effects of MDMA self administration?",
    "objectCQ": "What is the volume of the journal that discusses the effects of MDMA self administration?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35576531$49C54578-88E0-4C8B-9922-AA00C6A515C3",
    "theme": "ChemicalCompound",
    "subject_label": "Heat increases MDMA-enhanced NAcc 5-HT and body temperature, but not MDMA self-administration.",
    "subject_id": "Q35576531",
    "property_label": "volume",
    "property_id": "P478",
    "object_label": "20",
    "object_id": "",
    "context": "The volume of MDMA-enhanced NAcc 5-HT and body temperature increases, but not MDMA self-administration.",
    "propertyCQ": "What does MDMA-enhanced NAcc 5-HT increase in relation to body temperature?",
    "objectCQ": "How many times does MDMA increase body temperature?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44824030$7D05868B-424D-402A-9C7A-D0025ED5BF28",
    "theme": "ChemicalCompound",
    "subject_label": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "subject_id": "Q44824030",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "185-189",
    "object_id": "",
    "context": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. Page(s) 185-189.",
    "propertyCQ": "What is the number of pages that describe the validity of the in vivo [123I]beta-CIT SPECT?",
    "objectCQ": "What are the page numbers for the Validity of in vivo [123I]beta-CIT SPECT?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q57574540$68D8055E-EC03-4C42-90A9-9A2342E5338A",
    "theme": "ChemicalCompound",
    "subject_label": "Erratum: Involvement of Inferior Parietal Lobules in Prospective Memory Impairment During Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study",
    "subject_id": "Q57574540",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "1883-1884",
    "object_id": "",
    "context": "Erratum: Involvement of Inferior Parietal Lobules in Prospective Memory Impairment During Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study is 1883-1884.",
    "propertyCQ": "How many pages did the fMRI study cover?",
    "objectCQ": "When was the fMRI study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q31114156$5CD3000A-2828-4BB5-9C6C-7EEAD07CEAF0",
    "theme": "ChemicalCompound",
    "subject_label": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data",
    "subject_id": "Q31114156",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "81",
    "object_id": "",
    "context": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data is page(s) 81.",
    "propertyCQ": "What is page 81 of the study?",
    "objectCQ": "What is the number of pages that explore MDMA wastewater data?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q91787556$DC37215C-EE01-4719-8CBC-8037151F5821",
    "theme": "ChemicalCompound",
    "subject_label": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity",
    "subject_id": "Q91787556",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "01-Dec",
    "object_id": "",
    "context": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity, page(s) 1-12.",
    "propertyCQ": "What is the number of pages in the proof-of-principle study?",
    "objectCQ": "When did MDMA begin to have a positive effect on tinnitus?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69378319$ACB4FE96-29A0-4B27-A93E-3DC149A931AE",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats",
    "subject_id": "Q69378319",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "741-747",
    "object_id": "",
    "context": "The effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats are shown in page(s) 741-747.",
    "propertyCQ": "Where are the effects of MDMA on brain dopaminergic activity in rats shown?",
    "objectCQ": "What pages show the effects of MDMA on brain dopaminergic activity in rats?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q41022190$3D0AAE98-A1A4-4748-B38D-F4669BF2BE45",
    "theme": "ChemicalCompound",
    "subject_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q41022190",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "259-262",
    "object_id": "",
    "context": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). Page(s) 259-262.",
    "propertyCQ": "How many pages are there?",
    "objectCQ": "How many pages are there?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50426792$D6472393-9C0D-4F9E-A591-2AA88D3ACCA6",
    "theme": "ChemicalCompound",
    "subject_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subject_id": "Q50426792",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "11099-11106",
    "object_id": "",
    "context": "The page(s) 11099-11106 is about the environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "propertyCQ": "What is the name of the page that describes the concentrations of MDMA in the zebra mussel?",
    "objectCQ": "What is the name of the page that is about the concentrations of MDMA in the zebra mussel?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q68306116$B5B55D28-C4F2-482D-931C-2F70017FA5D4",
    "theme": "ChemicalCompound",
    "subject_label": "Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia",
    "subject_id": "Q68306116",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "371",
    "object_id": "",
    "context": "Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia, has page(s) 371.",
    "propertyCQ": "How many pages does MDMA have?",
    "objectCQ": "How many pages does MDMA have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83159822$1161DE4C-56B8-48BE-941C-3A91773E9094",
    "theme": "ChemicalCompound",
    "subject_label": "Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges",
    "subject_id": "Q83159822",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "15-22",
    "object_id": "",
    "context": "The differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges are page(s) 15-22.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40678302$9C9EDC03-4BBD-4617-977E-98269D205FD9",
    "theme": "ChemicalCompound",
    "subject_label": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "subject_id": "Q40678302",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "877-882",
    "object_id": "",
    "context": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "propertyCQ": "How many pages are there?",
    "objectCQ": "What is the number of days of the week that MDMA is given to rats?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$861193DD-A180-4BA3-8D20-DB0DF92638B2",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "249-263",
    "object_id": "",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. page(s) 249-263.",
    "propertyCQ": "249-263.",
    "objectCQ": "What are the page numbers for MDMA?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q42499116$DE2EE736-B952-490E-850E-1A7E4BDA6784",
    "theme": "ChemicalCompound",
    "subject_label": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "subject_id": "Q42499116",
    "property_label": "page(s)",
    "property_id": "P304",
    "object_label": "217-228",
    "object_id": "",
    "context": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats. Page(s) 217-228.",
    "propertyCQ": "How many pages are there in this study?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44824030$76B67B54-B5D2-44BE-B22B-6A867A737970",
    "theme": "ChemicalCompound",
    "subject_label": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "subject_id": "Q44824030",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/05/2004",
    "object_id": "",
    "context": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. Published on 01/05/2004.",
    "propertyCQ": "What was the publication date?",
    "objectCQ": "When was the validation of in vivo [123I]beta-CIT SPECT published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q57574540$55BB12E4-9FAF-4142-8FBC-1319FE455323",
    "theme": "ChemicalCompound",
    "subject_label": "Erratum: Involvement of Inferior Parietal Lobules in Prospective Memory Impairment During Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study",
    "subject_id": "Q57574540",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "12/05/2009",
    "object_id": "",
    "context": "Erratum: Involvement of Inferior Parietal Lobules in Prospective Memory Impairment During Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study was published on 12/05/2009.",
    "propertyCQ": "What was the publication date of the study?",
    "objectCQ": "When was the fMRI study published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q33907331$5CD02190-F381-400E-83B3-955141FBC214",
    "theme": "ChemicalCompound",
    "subject_label": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans.",
    "subject_id": "Q33907331",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/07/2000",
    "object_id": "",
    "context": "Acute psychological and physiological effects of MDMA (\"Ecstasy\") after haloperidol pretreatment in healthy humans. Published on 01/07/2000.",
    "propertyCQ": "What was the publication date of the study?",
    "objectCQ": "When was this study published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q91787556$9CF7E043-FB6E-43B6-9EE0-E7324B8E4430",
    "theme": "ChemicalCompound",
    "subject_label": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity",
    "subject_id": "Q91787556",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "06/01/2020",
    "object_id": "",
    "context": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity was published on 06/01/2020.",
    "propertyCQ": "What was the study's final date?",
    "objectCQ": "When was the proof-of-principle study published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69378319$98E6DDF5-16BB-4BA6-AEDF-B3E665D83CEC",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats",
    "subject_id": "Q69378319",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/08/1989",
    "object_id": "",
    "context": "The effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats were published on 01/08/1989.",
    "propertyCQ": "What was the date of the study?",
    "objectCQ": "When was MDMA first used in rats?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q41022190$E4E87DCD-2472-43EC-976A-3AC8553ADCD4",
    "theme": "ChemicalCompound",
    "subject_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q41022190",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/08/1994",
    "object_id": "",
    "context": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). The publication date was 01/08/1994.",
    "propertyCQ": "What was the release date of the CuZnSOD transgenic mice?",
    "objectCQ": "When was the publication date of the CuZnSOD transgenic mice?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50426792$9B950F9E-1D03-4F42-9F8E-76C1202390A0",
    "theme": "ChemicalCompound",
    "subject_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subject_id": "Q50426792",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/06/2014",
    "object_id": "",
    "context": "The zebra mussel was published on the 1st of June, 2014 and has an antioxidant enzyme activity that is modulated by environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA).",
    "propertyCQ": "What was the date of the zebra mussel's publication?",
    "objectCQ": "When was the zebra mussel published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q68306116$4A5B4D2A-9FC2-46D5-977E-074D3ADA03BA",
    "theme": "ChemicalCompound",
    "subject_label": "Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia",
    "subject_id": "Q68306116",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/06/1991",
    "object_id": "",
    "context": "Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia, was published on 01/06/1991.",
    "propertyCQ": "What was the death date of MDMA?",
    "objectCQ": "When was MDMA first published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83159822$5E626FF1-A0B9-4B2F-B789-3F82779D2367",
    "theme": "ChemicalCompound",
    "subject_label": "Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges",
    "subject_id": "Q83159822",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/01/2011",
    "object_id": "",
    "context": "MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges were published on 01/01/2011.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40678302$2F8DB588-793A-4918-A040-1F2CF7783B95",
    "theme": "ChemicalCompound",
    "subject_label": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "subject_id": "Q40678302",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/11/1995",
    "object_id": "",
    "context": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Published on 01/11/1995.",
    "propertyCQ": "What was the publication date?",
    "objectCQ": "When was this study published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$8778D803-1301-445C-B57E-ADC1300C1FF1",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "09/04/2004",
    "object_id": "",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Published on 09/04/2004.",
    "propertyCQ": "What was the date of the study?",
    "objectCQ": "When was this article published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q42499116$6DD9739C-CD55-4B4C-9BDA-C84AD7E395BE",
    "theme": "ChemicalCompound",
    "subject_label": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "subject_id": "Q42499116",
    "property_label": "publication date",
    "property_id": "P577",
    "object_label": "01/07/2006",
    "object_id": "",
    "context": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats. Published on 01/07/2006.",
    "propertyCQ": "What was the publication date?",
    "objectCQ": "When was this study published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44824030$E95D8729-BBB5-40C0-8729-D664448AA2A9",
    "theme": "ChemicalCompound",
    "subject_label": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "subject_id": "Q44824030",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "object_id": "",
    "context": "Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats.",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the purpose of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q51807530$36696656-19E5-4606-BB7A-10EA7C917215",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.",
    "subject_id": "Q51807530",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro",
    "object_id": "",
    "context": "Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the effect of MDMA on rat embryos?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q31114156$CA10FDD5-0689-4F2C-8A49-E6AD3A72A0A3",
    "theme": "ChemicalCompound",
    "subject_label": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data",
    "subject_id": "Q31114156",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data",
    "object_id": "",
    "context": "Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data has the title \"Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data\".",
    "propertyCQ": "",
    "objectCQ": "What is the title of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q91787556$3428D789-229B-48BA-8AD7-6F4DEC14C9F1",
    "theme": "ChemicalCompound",
    "subject_label": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity",
    "subject_id": "Q91787556",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity",
    "object_id": "",
    "context": "A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity is entitled \"A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity\".",
    "propertyCQ": "What is the name of the proof-of-principle study?",
    "objectCQ": "What is the name of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69378319$E9E2FF67-4D7E-4164-B6F7-D4E6E4B67ADF",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats",
    "subject_id": "Q69378319",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats",
    "object_id": "",
    "context": "The title of the study \"Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats\" is \"Effects of (+-)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats\".",
    "propertyCQ": "What is the study's title?",
    "objectCQ": "What is the title of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q41022190$30E34E6E-1471-40C3-8444-74D50CA33C18",
    "theme": "ChemicalCompound",
    "subject_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q41022190",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "object_id": "",
    "context": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA).",
    "propertyCQ": "What is the name of the article that describes the resistance of CuZnSOD transgenic mice to the lethal effects of MDA and MDMA?",
    "objectCQ": "What does CuZnSOD do?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50426792$C81E7A3E-C066-455E-B916-0B1C6603805B",
    "theme": "ChemicalCompound",
    "subject_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "subject_id": "Q50426792",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "object_id": "",
    "context": "Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel.",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the effect of MDMA on the zebra mussel?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q63212988$b52af881-42e9-d79e-64e7-61902d16d24d",
    "theme": "ChemicalCompound",
    "subject_label": "Amphoteronolide B",
    "subject_id": "Q63212988",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Total synthesis of amphoteronolide B",
    "object_id": "",
    "context": "Amphoteronolide B is a total synthesis of amphoteronolide B.",
    "propertyCQ": "What is the name of the synthesis?",
    "objectCQ": "What is amphoteronolide B?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83159822$1E0C0C77-5EA9-42A2-8128-9D669958A258",
    "theme": "ChemicalCompound",
    "subject_label": "Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges",
    "subject_id": "Q83159822",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges",
    "object_id": "",
    "context": "The title of the book \"Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges\" is \"Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges\".",
    "propertyCQ": "What is the title of the book?",
    "objectCQ": "What is the title of the book?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40678302$354E5432-2A3F-43E8-82CA-BDC536BD5F7D",
    "theme": "ChemicalCompound",
    "subject_label": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "subject_id": "Q40678302",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "object_id": "",
    "context": "Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing.",
    "propertyCQ": "What is the title of the article?",
    "objectCQ": "What is the effect of MDMA on rats?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$C800AA6D-177A-48AE-940A-ED339751C26B",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "object_id": "",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the effect of MDMA on the brain?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q42499116$F953B4AF-959A-403F-9454-7DFC5E4347E5",
    "theme": "ChemicalCompound",
    "subject_label": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "subject_id": "Q42499116",
    "property_label": "title",
    "property_id": "P1476",
    "object_label": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "object_id": "",
    "context": "Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.",
    "propertyCQ": "What is the title of the study?",
    "objectCQ": "What is the effect of MDMA on the rat?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69379487$60D82478-5CFF-4D4E-8071-3B7129878BF5",
    "theme": "ChemicalCompound",
    "subject_label": "Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine",
    "subject_id": "Q69379487",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "NIDA research monograph",
    "object_id": "Q27712234",
    "context": "Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine was published in the NIDA research monograph.",
    "propertyCQ": "What was the NIDA research monograph?",
    "objectCQ": "Where was the comparison of the behavioral and neurochemical effects of MDMA and MDMA published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q51073688$080B863C-7FB5-40EA-84F9-9B41C4D45610",
    "theme": "ChemicalCompound",
    "subject_label": "(+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats.",
    "subject_id": "Q51073688",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "European Journal of Pharmacology",
    "object_id": "Q1376712",
    "context": "(+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. Published in the European Journal of Pharmacology.",
    "propertyCQ": "What journal is MDMA published in?",
    "objectCQ": "Where is MDMA published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q47731855$7EA0805E-FFED-435A-BB10-9518F66D2E87",
    "theme": "ChemicalCompound",
    "subject_label": "Oxytocin and MDMA ('Ecstasy') enhance social reward in rats.",
    "subject_id": "Q47731855",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Psychopharmacology",
    "object_id": "Q1422802",
    "context": "Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Published in Psychopharmacology.",
    "propertyCQ": "What is the name of the journal that studies the effects of MDMA and Oxytocin on rats?",
    "objectCQ": "Where was Ecstasy published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q41022190$89D1654D-EA0B-4B79-B90A-B8BF0A4FD0D2",
    "theme": "ChemicalCompound",
    "subject_label": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q41022190",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Brain Research",
    "object_id": "Q4955782",
    "context": "CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA). This study was published in Brain Research.",
    "propertyCQ": "What journal did the study on CuZnSOD be published in?",
    "objectCQ": "What journal was the study published in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50064627$1D53F9EA-C822-4A69-9414-7871BBF400D8",
    "theme": "ChemicalCompound",
    "subject_label": "Development of microwave-assisted extraction procedure for organic impurity profiling of seized 3,4-methylenedioxymethamphetamine (MDMA).",
    "subject_id": "Q50064627",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Journal of Forensic Sciences",
    "object_id": "Q15760026",
    "context": "Development of microwave-assisted extraction procedure for organic impurity profiling of seized 3,4-methylenedioxymethamphetamine (MDMA) was published in the Journal of Forensic Sciences.",
    "propertyCQ": "What journal was the development of the microwave-assisted extraction procedure published in?",
    "objectCQ": "What journal was the development of the microwave-assisted extraction procedure published in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46913606$500B663B-25BC-4F1F-9C35-CFA3D3A93EBC",
    "theme": "ChemicalCompound",
    "subject_label": "MDMA, politics and medical research: have we thrown the baby out with the bathwater?",
    "subject_id": "Q46913606",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Journal of Psychopharmacology",
    "object_id": "Q6295819",
    "context": "MDMA, politics and medical research: have we thrown the baby out with the bathwater? was published in the Journal of Psychopharmacology.",
    "propertyCQ": "What journal was the Journal of Psychopharmacology published in?",
    "objectCQ": "Where was MDMA published?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q48608076$684EB37E-504A-407C-AA03-4A68C586AC5D",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats.",
    "subject_id": "Q48608076",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Pharmacology, Biochemistry and Behavior",
    "object_id": "Q15716554",
    "context": "Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats. Published in Pharmacology, Biochemistry and Behavior.",
    "propertyCQ": "What is the name of the journal that published the study?",
    "objectCQ": "What journal was the study published in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50921579$85FFCCA6-F297-4495-A00A-3C348ADF4DFA",
    "theme": "ChemicalCompound",
    "subject_label": "The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.",
    "subject_id": "Q50921579",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Psychopharmacology",
    "object_id": "Q1422802",
    "context": "The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans was published in Psychopharmacology.",
    "propertyCQ": "What journal was the study of the effects of fluoxetine on MDMA in humans published in?",
    "objectCQ": "What journal published the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46416925$E5C952E0-824E-4C67-ABA3-DCBF1507155A",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.",
    "subject_id": "Q46416925",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Brain Research",
    "object_id": "Q4955782",
    "context": "Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide. Published in Brain Research.",
    "propertyCQ": "What journal was the study published in?",
    "objectCQ": "What journal was the study published in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q43453796$8079CEDD-23D3-4085-87C3-78957EF448D4",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice.",
    "subject_id": "Q43453796",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Addiction Biology",
    "object_id": "Q4681109",
    "context": "The study of the effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice was published in Addiction Biology.",
    "propertyCQ": "What journal was the study published in?",
    "objectCQ": "What journal published the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$3877EFB6-C6BA-4079-9BF5-394AC2317C4F",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Psychopharmacology",
    "object_id": "Q1422802",
    "context": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Published in Psychopharmacology.",
    "propertyCQ": "What is the name of the journal that studies the effects of MDMA on dopamine biochemistry?",
    "objectCQ": "What journal is this article published in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37392237$002EA348-E57F-4F7A-8F94-8FC9E6101CB7",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.",
    "subject_id": "Q37392237",
    "property_label": "published in",
    "property_id": "P1433",
    "object_label": "Pharmacology, Biochemistry and Behavior",
    "object_id": "Q15716554",
    "context": "The study of the effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats was published in Pharmacology, Biochemistry and Behavior.",
    "propertyCQ": "",
    "objectCQ": "What journal was the study published in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591930$2F5C1A60-729C-41EF-94C6-EB0674D5C76C",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-3195",
    "subject_id": "Q27591930",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR3195",
    "object_id": "Q20781704",
    "context": "Hsa-mir-3195 is encoded by MIR3195.",
    "propertyCQ": "What is the Hsa-mir-3195?",
    "objectCQ": "What is the name of the encoder that encodes Hsa-mir-3195?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591435$B7236BFB-AE14-4FFB-AF78-6D4BB56BA3E6",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-1180",
    "subject_id": "Q27591435",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR1180",
    "object_id": "Q18065920",
    "context": "Hsa-mir-1180 is encoded by MIR1180.",
    "propertyCQ": "What is the Hsa-mir-1180?",
    "objectCQ": "What is the name of the device that encodes Hsa-mir-1180?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592196$6B71EAC5-1E35-4AD9-BAFC-79224B2B578D",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-4636",
    "subject_id": "Q27592196",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR4636",
    "object_id": "Q18068731",
    "context": "Hsa-mir-4636 is encoded by MIR4636.",
    "propertyCQ": "What is Hsa-mir-4636?",
    "objectCQ": "What is the name of the encoder that encodes Hsa-mir-4636?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592523$692A91CF-0EC4-48B9-85EE-9C2763CD16D8",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-3651",
    "subject_id": "Q27592523",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR3651",
    "object_id": "Q20782053",
    "context": "Hsa-mir-3651 is encoded by MIR3651.",
    "propertyCQ": "What is Hsa-mir-3651?",
    "objectCQ": "What is the encoder of Hsa-mir-3651?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50422748$008F7D7B-0249-4005-80DB-91BE1975D7CE",
    "theme": "ChemicalCompound",
    "subject_label": "tRNA-Tyr encoded by: tyrU b3977",
    "subject_id": "Q50422748",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "tyrU encodes: tRNA-Tyr b3977",
    "object_id": "Q50422733",
    "context": "TRNA-Tyr is encoded by: tyrU b3977 and tyrU encodes tRNA-Tyr b3977.",
    "propertyCQ": "What is TRNA-Tyr?",
    "objectCQ": "What does tyrU encode?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592300$AB766E47-82F0-447C-96A2-91BE409D2EAE",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-548u",
    "subject_id": "Q27592300",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR548U",
    "object_id": "Q20773952",
    "context": "Hsa-mir-548u is encoded by MIR548U.",
    "propertyCQ": "What is the Hsa-mir-548u?",
    "objectCQ": "What is the name of the device that encodes Hsa-mir-548u?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q483745$956614D7-0823-4DB1-936E-66522556643D",
    "theme": "ChemicalCompound",
    "subject_label": "L-leucine",
    "subject_id": "Q483745",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "CUG",
    "object_id": "Q29018180",
    "context": "L-leucine is encoded by CUG.",
    "propertyCQ": "What is L-leucine encoded by?",
    "objectCQ": "What is the name of the entity that encodes L-leucine?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591978$302E3BBD-BD47-4010-A4B4-ECA91DFB0B89",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-1306",
    "subject_id": "Q27591978",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "GGT2",
    "object_id": "Q18061420",
    "context": "Hsa-mir-1306 is encoded by GGT2.",
    "propertyCQ": "What is the Hsa-mir-1306 encoded by?",
    "objectCQ": "What is the encoder of Hsa-mir-1306?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591294$76ED00EF-7135-49DB-890F-C080FB3CBCB4",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-190a",
    "subject_id": "Q27591294",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR190A",
    "object_id": "Q18058090",
    "context": "Hsa-mir-190a is encoded by MIR190A.",
    "propertyCQ": "What is the Hsa-mir-190a?",
    "objectCQ": "What is the encoder of Hsa-mir-190a?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27590969$55C9641A-58BC-4AC4-AD26-0D96B6433CAF",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-6748",
    "subject_id": "Q27590969",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR6748",
    "object_id": "Q18075153",
    "context": "Hsa-mir-6748 is encoded by MIR6748.",
    "propertyCQ": "What is the Hsa-mir-6748?",
    "objectCQ": "What is the name of the encoder that encodes Hsa-mir-6748?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591319$7D7ABD0B-7086-4C4A-A91E-09CE9EC544F8",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-3529",
    "subject_id": "Q27591319",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "DDX11L5",
    "object_id": "Q18065540",
    "context": "Hsa-mir-3529 is encoded by DDX11L5.",
    "propertyCQ": "What is the DDX11L5?",
    "objectCQ": "What is the code used by?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592349$71512AE2-5650-43E1-BE96-5F8A71747C12",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-6837",
    "subject_id": "Q27592349",
    "property_label": "encoded by",
    "property_id": "P702",
    "object_label": "MIR6837",
    "object_id": "Q18080790",
    "context": "Hsa-mir-6837 is encoded by MIR6837.",
    "propertyCQ": "What is the name of the MIR6837?",
    "objectCQ": "What is the name of the encoder that encodes Hsa-mir-6837?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q421862$26511AC2-9A7C-4147-A726-6B2BABA67A9C",
    "theme": "ChemicalCompound",
    "subject_label": "ribavirin",
    "subject_id": "Q421862",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Virazole",
    "object_id": "Q47522301",
    "context": "Virazole is an active ingredient of ribavirin.",
    "propertyCQ": "What is virazole?",
    "objectCQ": "What is the active ingredient of ribavirin?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q238490$690523A9-944B-4F2D-A4C2-7449FDD525B9",
    "theme": "ChemicalCompound",
    "subject_label": "5-fluorocytosine",
    "subject_id": "Q238490",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Ancobon",
    "object_id": "Q47521050",
    "context": "Ancobon contains the active ingredient 5-fluorocytosine.",
    "propertyCQ": "What is 5-fluorocytosine?",
    "objectCQ": "What contains the active ingredient 5-fluorocytosine?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q4391540$2bfbda36-4fd9-6e12-ecb0-a41691e0e522",
    "theme": "ChemicalCompound",
    "subject_label": "interferon Alfa-2b, Recombinant",
    "subject_id": "Q4391540",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Oftalmoferon",
    "object_id": "Q4340338",
    "context": "The active ingredient in oftalmoferon is interferon Alfa-2b, recombinant.",
    "propertyCQ": "What is interferon Alfa-2b?",
    "objectCQ": "What is the active ingredient in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2552927$B1571833-DD48-4ACA-9A64-E6C656AF2C8C",
    "theme": "ChemicalCompound",
    "subject_label": "cefepime",
    "subject_id": "Q2552927",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Maxipime",
    "object_id": "Q47521328",
    "context": "Cefepime is an active ingredient in Maxipime.",
    "propertyCQ": "What is Cefepime?",
    "objectCQ": "What drug contains Cefepime?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3315722$6CB41239-58B6-4306-BDEF-60485A243B2A",
    "theme": "ChemicalCompound",
    "subject_label": "mipomersen",
    "subject_id": "Q3315722",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Kynamro",
    "object_id": "Q29006100",
    "context": "Kynamro is an active ingredient in mipomersen.",
    "propertyCQ": "What is Kynamro?",
    "objectCQ": "What is an active ingredient in mipomersen?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q194974$EFFA1BD8-C850-4B9D-94DA-6E3EC0204069",
    "theme": "ChemicalCompound",
    "subject_label": "letrozole",
    "subject_id": "Q194974",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Femara",
    "object_id": "Q47521599",
    "context": "Letrozole is an active ingredient in Femara.",
    "propertyCQ": "What is Letrozole?",
    "objectCQ": "What is Letrozole an active ingredient in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q412174$D319241B-8898-4E9F-AE1A-ECA239A0EB7C",
    "theme": "ChemicalCompound",
    "subject_label": "pregabalin",
    "subject_id": "Q412174",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Pregabalin Sandoz Gmbh",
    "object_id": "Q29006364",
    "context": "Pregabalin is an active ingredient in Pregabalin Sandoz Gmbh.",
    "propertyCQ": "What is Pregabalin?",
    "objectCQ": "Pregabalin is an active ingredient in what drug?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q409251$04C55BAD-1364-4401-8108-1139B77DF1B9",
    "theme": "ChemicalCompound",
    "subject_label": "calcium acetate",
    "subject_id": "Q409251",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Eliphos",
    "object_id": "Q48828221",
    "context": "Eliphos contains calcium acetate as an active ingredient.",
    "propertyCQ": "What does Eliphos contain calcium acetate as?",
    "objectCQ": "What is the name of the product that contains calcium acetate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q412174$90A7645F-7C74-44F9-B829-D0A1C658CBAB",
    "theme": "ChemicalCompound",
    "subject_label": "pregabalin",
    "subject_id": "Q412174",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Pregabalin Accord",
    "object_id": "Q29006359",
    "context": "Pregabalin Accord contains pregabalin as an active ingredient.",
    "propertyCQ": "What does Pregabalin Accord contain?",
    "objectCQ": "What contains pregabalin as an active ingredient?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q166825$859DBFF7-42D0-4988-92C5-4F0A9DEAD6F2",
    "theme": "ChemicalCompound",
    "subject_label": "ibandronic acid",
    "subject_id": "Q166825",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Bondenza",
    "object_id": "Q29004907",
    "context": "Ibandronic acid is an active ingredient in Bondenza.",
    "propertyCQ": "What is Ibandronic acid?",
    "objectCQ": "Ibandronic acid is an active ingredient in what drug?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q684379$56A0F928-FD52-41F2-8582-B9D121A1EFE4",
    "theme": "ChemicalCompound",
    "subject_label": "nepafenac",
    "subject_id": "Q684379",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Ilevro",
    "object_id": "Q48828192",
    "context": "Nepafenac is an active ingredient in ilevro.",
    "propertyCQ": "What is Nepafenac?",
    "objectCQ": "Nepafenac is an active ingredient in what drug?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q415909$032AA816-5D9E-4F62-8C34-33347D34AF0A",
    "theme": "ChemicalCompound",
    "subject_label": "capreomycin",
    "subject_id": "Q415909",
    "property_label": "active ingredient in",
    "property_id": "P3780",
    "object_label": "Capastat",
    "object_id": "Q47521312",
    "context": "Capastat is an active ingredient of capreomycin.",
    "propertyCQ": "What is capastat?",
    "objectCQ": "What is the active ingredient of capreomycin?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q183554$296C6740-D71E-41A7-8981-5002190AFB0E",
    "theme": "ChemicalCompound",
    "subject_label": "fosfomycin",
    "subject_id": "Q183554",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "fosfomycin",
    "object_id": "",
    "context": "The World Health Organisation International Nonproprietary Name of fosfomycin is fosfomycin.",
    "propertyCQ": "What is fosfomycin?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2937681$A98F8532-F04E-408F-A590-BBC3816D5813",
    "theme": "ChemicalCompound",
    "subject_label": "captodiame",
    "subject_id": "Q2937681",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "Captodiame",
    "object_id": "",
    "context": "Captodiame is a World Health Organisation International Nonproprietary Name.",
    "propertyCQ": "What is Captodiame?",
    "objectCQ": "What is the World Health Organization's Nonproprietary Name?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q5057303$3413B2DF-0291-4B88-926D-2E8A96DAB6CC",
    "theme": "ChemicalCompound",
    "subject_label": "cefuzonam",
    "subject_id": "Q5057303",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "cefuzonam",
    "object_id": "",
    "context": "Cefuzonam is a World Health Organisation International Nonproprietary Name.",
    "propertyCQ": "What is Cefuzonam?",
    "objectCQ": "What is the name of the World Health Organization's Nonproprietary Name?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q71969$25AAFBD3-4561-413E-80E5-EE496BC8CBC4",
    "theme": "ChemicalCompound",
    "subject_label": "methenamine",
    "subject_id": "Q71969",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "methenamine",
    "object_id": "",
    "context": "Methenamine is an international nonproprietary name of the World Health Organisation.",
    "propertyCQ": "What is Methenamine?",
    "objectCQ": "What is the name of the nonproprietary name of the World Health Organization?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q416427$0A6A5BD7-0440-490E-936E-8A6D8BCD5332",
    "theme": "ChemicalCompound",
    "subject_label": "cromoglicic acid",
    "subject_id": "Q416427",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "cromoglicic acid",
    "object_id": "",
    "context": "Cromoglicic acid is a World Health Organisation International Nonproprietary Name.",
    "propertyCQ": "What is Cromoglicic acid?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3800087$B450A5C1-9134-4A97-A1DC-A6AE5773BA96",
    "theme": "ChemicalCompound",
    "subject_label": "pyrilamine",
    "subject_id": "Q3800087",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "Mepyramine",
    "object_id": "",
    "context": "The International Nonproprietary Name of pyrilamine is Mepyramine and the World Health Organisation.",
    "propertyCQ": "What is the name of pyrilamine?",
    "objectCQ": "What is the International Nonproprietary Name of pyrilamine?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q176533$F7D9DE5A-712E-4EC6-ADC3-47694E3C8340",
    "theme": "ChemicalCompound",
    "subject_label": "alfentanil",
    "subject_id": "Q176533",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "alfentanil",
    "object_id": "",
    "context": "The World Health Organisation International Nonproprietary Name of alfentanil is alfentanil.",
    "propertyCQ": "What is the name of the drug alfentanil?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7107372$82F965C7-33B1-4B3A-A6CA-63F6ADA1E2E8",
    "theme": "ChemicalCompound",
    "subject_label": "ospemifene",
    "subject_id": "Q7107372",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "Ospemifene",
    "object_id": "",
    "context": "Ospemifene is a World Health Organisation International Nonproprietary Name.",
    "propertyCQ": "What is Ospemifene?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q24255323$179CA84C-2213-40CC-85F6-26B51FB9CFDD",
    "theme": "ChemicalCompound",
    "subject_label": "esatenolol",
    "subject_id": "Q24255323",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "esatenolol",
    "object_id": "",
    "context": "Esatenolol is a World Health Organisation International Nonproprietary Name.",
    "propertyCQ": "What is Esatenolol?",
    "objectCQ": "What is the World Health Organization's Nonproprietary Name?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q422438$03C30FF6-D046-4B47-ACED-DA5D22A8E146",
    "theme": "ChemicalCompound",
    "subject_label": "chloroquine",
    "subject_id": "Q422438",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "chloroquine",
    "object_id": "",
    "context": "The World Health Organisation International Nonproprietary Name of chloroquine is chloroquine.",
    "propertyCQ": "What is the name of chloroquine?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20817136$05223814-EB9F-406D-BDED-417F10578B32",
    "theme": "ChemicalCompound",
    "subject_label": "Hydroxystilbamidine Isethionate",
    "subject_id": "Q20817136",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "Hydroxystilbamidine isethionate",
    "object_id": "",
    "context": "The World Health Organisation International Nonproprietary Name of Hydroxystilbamidine is Hydroxystilbamidine isethionate.",
    "propertyCQ": "What is Hydroxystilbamidine isethionate?",
    "objectCQ": "What is the World Health Organization's International Nonproprietary Name of Hydroxystilbamidine?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27124363$E3D273F1-C8B1-4CC3-A758-446079B32D5A",
    "theme": "ChemicalCompound",
    "subject_label": "4-amino-m-cresol",
    "subject_id": "Q27124363",
    "property_label": "World Health Organisation International Nonproprietary Name",
    "property_id": "P2275",
    "object_label": "sulfamoxole",
    "object_id": "",
    "context": "4-amino-m-cresol is the World Health Organisation International Nonproprietary Name of sulfamoxole.",
    "propertyCQ": "What is 4-amino-m-cresol?",
    "objectCQ": "What is the World Health Organization's Nonproprietary Name of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58375$C979D86C-547D-4324-B0D6-C7750A5B77CA",
    "theme": "ChemicalCompound",
    "subject_label": "thioridazine",
    "subject_id": "Q58375",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "dofetilide",
    "object_id": "Q3712521",
    "context": "Dofetilide is a significant drug interaction between thioridazine and dofetilide.",
    "propertyCQ": "What is dofetilide?",
    "objectCQ": "What is a significant drug interaction between thioridazine and?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58375$EA8BF589-1925-46BF-929A-25F3DFFB9A96",
    "theme": "ChemicalCompound",
    "subject_label": "thioridazine",
    "subject_id": "Q58375",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "quinidine",
    "object_id": "Q412496",
    "context": "Thioridazine has a significant drug interaction with quinidine.",
    "propertyCQ": "What does Thioridazine have with quinidine?",
    "objectCQ": "Thioridazine has a significant drug interaction with what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425120$5735B29D-593F-41A2-B9C9-70ECB0C9588A",
    "theme": "ChemicalCompound",
    "subject_label": "disopyramide",
    "subject_id": "Q425120",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "probucol",
    "object_id": "Q10354103",
    "context": "Disopyramide has a significant drug interaction with probucol.",
    "propertyCQ": "What does disopyramide have with probucol?",
    "objectCQ": "Disopyramide has a significant drug interaction with what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7739$C62F5C56-77FD-493E-BD6B-D7C343261A8A",
    "theme": "ChemicalCompound",
    "subject_label": "arsenic trioxide",
    "subject_id": "Q7739",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "escitalopram",
    "object_id": "Q423757",
    "context": "Escitalopram has a significant drug interaction with arsenic trioxide.",
    "propertyCQ": "What does escalopram have with arsenic trioxide?",
    "objectCQ": "What drug has a significant drug interaction with arsenic trioxide?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q1649219$62E5DC41-76B5-4551-82BF-9DB6FE51BD1F",
    "theme": "ChemicalCompound",
    "subject_label": "phendimetrazine",
    "subject_id": "Q1649219",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "phenelzine",
    "object_id": "Q1747559",
    "context": "Phenelzine is a significant drug interaction with phendimetrazine.",
    "propertyCQ": "What is phenelzine?",
    "objectCQ": "What is a significant drug interaction with phendimetrazine?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q6821618$B927277A-9D1A-4E3B-B347-0BA12F882160",
    "theme": "ChemicalCompound",
    "subject_label": "mesoridazine",
    "subject_id": "Q6821618",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "pimozide",
    "object_id": "Q144085",
    "context": "Mesoridazine has a significant drug interaction with pimozide.",
    "propertyCQ": "What is the relationship between pimozide and mesoridazine?",
    "objectCQ": "Mesoridazine has a significant drug interaction with what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q6821618$FA41A5F2-0360-49D7-B01F-6BF24B3888BB",
    "theme": "ChemicalCompound",
    "subject_label": "mesoridazine",
    "subject_id": "Q6821618",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "chlorpromazine",
    "object_id": "Q407972",
    "context": "Mesoridazine has a significant drug interaction with chlorpromazine.",
    "propertyCQ": "What does mesoridazine have with chlorpromazine?",
    "objectCQ": "Mesoridazine has a significant drug interaction with what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425120$FE2AAC73-CC86-4AB4-ABD9-0E4EAB7C8388",
    "theme": "ChemicalCompound",
    "subject_label": "disopyramide",
    "subject_id": "Q425120",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "astemizole",
    "object_id": "Q423437",
    "context": "Astemizole has a significant drug interaction with disopyramide.",
    "propertyCQ": "What does astemizole have with disopyramide?",
    "objectCQ": "What drug has a significant drug interaction with disopyramide?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q251347$07FCFB4E-2A00-47F6-A376-F8735376C2E6",
    "theme": "ChemicalCompound",
    "subject_label": "haloperidol",
    "subject_id": "Q251347",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "sparfloxacin",
    "object_id": "Q976559",
    "context": "Haloperidol and sparfloxacin are significant drug interactions.",
    "propertyCQ": "What are haloperidol and sparfloxacin?",
    "objectCQ": "Haloperidol and what other drug are significant drug interactions?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58375$9239CEC0-0773-4722-9045-656A4DCF62A4",
    "theme": "ChemicalCompound",
    "subject_label": "thioridazine",
    "subject_id": "Q58375",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "pimozide",
    "object_id": "Q144085",
    "context": "Thioridazine has a significant drug interaction with pimozide.",
    "propertyCQ": "What is the relationship between Thioridazine and pimozide?",
    "objectCQ": "Thioridazine has a significant drug interaction with what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58375$798ECADD-A64B-4BE8-8BDA-9FFB0643E18F",
    "theme": "ChemicalCompound",
    "subject_label": "thioridazine",
    "subject_id": "Q58375",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "terfenadine",
    "object_id": "Q417909",
    "context": "Thioridazine has a significant drug interaction with terfenadine.",
    "propertyCQ": "What is the relationship between thioridazine and terfenadine?",
    "objectCQ": "Thioridazine has a significant drug interaction with what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7739$3F6915AD-D8B2-4B0C-9AB8-B953BFEEE124",
    "theme": "ChemicalCompound",
    "subject_label": "arsenic trioxide",
    "subject_id": "Q7739",
    "property_label": "significant drug interaction",
    "property_id": "P769",
    "object_label": "domperidone",
    "object_id": "Q424238",
    "context": "Domperidone is a significant drug interaction with arsenic trioxide.",
    "propertyCQ": "What is Domperidone?",
    "objectCQ": "What is a drug that has a significant interaction with arsenic trioxide?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11498826$3d956cd8-4ab7-a570-bc3c-4114d79f2d1a",
    "theme": "ChemicalCompound",
    "subject_label": "Shikotsu Onsen",
    "subject_id": "Q11498826",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Chitose",
    "object_id": "Q693237",
    "context": "Shikotsu Onsen is located in the administrative territorial entity of Chitose.",
    "propertyCQ": "Where is Shikotsu Onsen located?",
    "objectCQ": "Shikotsu Onsen is located in what administrative territorial entity?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3137477$93b70547-4a2b-d6ba-d1ce-57e96ff59ec2",
    "theme": "ChemicalCompound",
    "subject_label": "Kusatsu Onsen",
    "subject_id": "Q3137477",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Kusatsu",
    "object_id": "Q1358949",
    "context": "Kusatsu Onsen is located in the administrative territorial entity of Kusatsu.",
    "propertyCQ": "Where is Kusatsu Onsen located?",
    "objectCQ": "Where is Kusatsu Onsen located?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11642937$d497f935-4694-3323-db78-67c9b4a28ba6",
    "theme": "ChemicalCompound",
    "subject_label": "那須温泉郷",
    "subject_id": "Q11642937",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Kantō region",
    "object_id": "Q132480",
    "context": "那須温泉郷 is located in the administrative territorial entity of the Kantō region.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11580978$49384a28-45b5-b7d4-ffa9-31794a7ea7be",
    "theme": "ChemicalCompound",
    "subject_label": "Kaike Onsen",
    "subject_id": "Q11580978",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Tottori Prefecture",
    "object_id": "Q133935",
    "context": "Kaike Onsen is located in the administrative territorial entity of Tottori Prefecture.",
    "propertyCQ": "Where is Kaike Onsen located?",
    "objectCQ": "What is Kaike Onsen located in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q908993$c5014ee2-4769-b96f-cc94-87ccda60bea4",
    "theme": "ChemicalCompound",
    "subject_label": "Hakone Onsen",
    "subject_id": "Q908993",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Hakone",
    "object_id": "Q671040",
    "context": "Hakone Onsen is located in the administrative territorial entity of Hakone.",
    "propertyCQ": "Where is Hakone Onsen located?",
    "objectCQ": "What is the administrative territorial entity of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7849922$bc55b09e-41d1-c86d-6abe-fc69d885c42d",
    "theme": "ChemicalCompound",
    "subject_label": "Tsuchiyu Onsen",
    "subject_id": "Q7849922",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Fukushima",
    "object_id": "Q161176",
    "context": "Tsuchiyu Onsen is located in the administrative territorial entity of Fukushima.",
    "propertyCQ": "Where is Tsuchiyu Onsen located?",
    "objectCQ": "Where is Tsuchiyu Onsen located?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11645764$83b7b66c-4068-d05e-b6ab-942caff3281c",
    "theme": "ChemicalCompound",
    "subject_label": "Nozawa Onsen",
    "subject_id": "Q11645764",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Nozawaonsen",
    "object_id": "Q1354760",
    "context": "Nozawa Onsen is located in the administrative territorial entity of Nozawaonsen.",
    "propertyCQ": "Where is Nozawa Onsen located?",
    "objectCQ": "What is the administrative territorial entity of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11563450$db1ae6b7-43c3-3911-bccd-0802b2b415c2",
    "theme": "ChemicalCompound",
    "subject_label": "湯ヶ島温泉",
    "subject_id": "Q11563450",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Shizuoka Prefecture",
    "object_id": "Q131320",
    "context": "湯ヶ島温泉 is located in the administrative territorial entity of Shizuoka Prefecture.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11356664$9ce1fd32-4e66-50a7-612a-367a4fab7aa8",
    "theme": "ChemicalCompound",
    "subject_label": "三瓶温泉",
    "subject_id": "Q11356664",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Shimane Prefecture",
    "object_id": "Q132751",
    "context": "三瓶温泉 is located in the administrative territorial entity of Shimane Prefecture.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q28692475$0b54a8e9-478d-1877-264f-e6737052f997",
    "theme": "ChemicalCompound",
    "subject_label": "海津温泉",
    "subject_id": "Q28692475",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Kaizu",
    "object_id": "Q844056",
    "context": "海津温泉 is located in the administrative territorial entity of Kaizu.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11585331$c5660343-46d6-907c-d8d1-910018cfc71b",
    "theme": "ChemicalCompound",
    "subject_label": "石和温泉",
    "subject_id": "Q11585331",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Kōshin'etsu region",
    "object_id": "Q398208",
    "context": "石和温泉 is located in the administrative territorial entity of the Kōshin'etsu region.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11572001$15cb8257-4087-e097-e04e-3be38c30797b",
    "theme": "ChemicalCompound",
    "subject_label": "猫啼温泉",
    "subject_id": "Q11572001",
    "property_label": "located in the administrative territorial entity",
    "property_id": "P131",
    "object_label": "Ishikawa",
    "object_id": "Q1205335",
    "context": "猫啼温泉 is located in the administrative territorial entity of Ishikawa.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q421930$B4D0388E-A3D1-4497-AFB4-722A26C4451B",
    "theme": "ChemicalCompound",
    "subject_label": "mirtazapine",
    "subject_id": "Q421930",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Adrenoceptor alpha 2A",
    "object_id": "Q4734892",
    "context": "Mirtazapine interacts physically with Adrenoceptor alpha 2A.",
    "propertyCQ": "How does Mirtazapine interact with Adrenoceptor alpha 2A?",
    "objectCQ": "What does Mirtazapine interact with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q4646881$25011DE2-19C8-46F8-A49E-8E01F9A4AF2E",
    "theme": "ChemicalCompound",
    "subject_label": "A-68930",
    "subject_id": "Q4646881",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Dopamine receptor D5",
    "object_id": "Q21131500",
    "context": "A-68930 interacts physically with the Dopamine receptor D5.",
    "propertyCQ": "How does A-68930 interact with the Dopamine receptor?",
    "objectCQ": "What does A-68930 interact with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q407426$0B052587-DAE3-444B-82EC-941109DA7CB1",
    "theme": "ChemicalCompound",
    "subject_label": "linoleic acid",
    "subject_id": "Q407426",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Potassium voltage-gated channel subfamily B member 1",
    "object_id": "Q21107884",
    "context": "Linoleic acid physically interacts with Potassium voltage-gated channel subfamily B member 1.",
    "propertyCQ": "How does linoleic acid interact with Potassium voltage-gated channel subfamily B member 1?",
    "objectCQ": "What does linoleic acid physically interact with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q12745785$6FA01608-3EE1-4FD9-8DB9-0EEBEF23A5EF",
    "theme": "ChemicalCompound",
    "subject_label": "lorglumide",
    "subject_id": "Q12745785",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Cholecystokinin B receptor",
    "object_id": "Q21110901",
    "context": "Lorglumide interacts physically with the Cholecystokinin B receptor.",
    "propertyCQ": "How does Lorglumide interact with the Cholecystokinin B receptor?",
    "objectCQ": "What does Lorglumide interact with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q6085784$B1EB45DF-2450-430D-9FE9-FB260CF8970C",
    "theme": "ChemicalCompound",
    "subject_label": "isoguvacine",
    "subject_id": "Q6085784",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Gamma-aminobutyric acid type A receptor subunit alpha4",
    "object_id": "Q5512777",
    "context": "The isoguvacine interacts with the Gamma-aminobutyric acid type A receptor subunit alpha4.",
    "propertyCQ": "How does isoguvacine interact with the receptor subunit alpha4?",
    "objectCQ": "What does isoguvacine interact with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q4652514$477C2956-455B-4D29-8B35-97DECA036EDE",
    "theme": "ChemicalCompound",
    "subject_label": "AM-251",
    "subject_id": "Q4652514",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "G protein-coupled receptor 55",
    "object_id": "Q21110942",
    "context": "AM-251 interacts physically with the G protein-coupled receptor 55.",
    "propertyCQ": "How does AM-251 interact with the G protein-coupled receptor 55?",
    "objectCQ": "What does AM-251 interact with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q384295$6409B2EF-6398-4B2E-A9D1-8D3AEFF0ABA2",
    "theme": "ChemicalCompound",
    "subject_label": "gemfibrozil",
    "subject_id": "Q384295",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Solute carrier organic anion transporter family member 1B3",
    "object_id": "Q21125248",
    "context": "Gemfibrozil interacts physically with the Solute carrier organic anion transporter family member 1B3.",
    "propertyCQ": "How does Gemfibrozil interact with the Solute carrier organic anion transporter family member 1B3?",
    "objectCQ": "Gemfibrozil interacts physically with what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q417240$6942C98F-4B2A-4ABC-8577-F76EB29F730C",
    "theme": "ChemicalCompound",
    "subject_label": "atomoxetine",
    "subject_id": "Q417240",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Solute carrier family 6 member 3",
    "object_id": "Q2271947",
    "context": "Atomoxetine physically interacts with Solute carrier family 6 member 3.",
    "propertyCQ": "How does Atomoxetine interact with Solute carrier family 6 member 3?",
    "objectCQ": "Atomoxetine physically interacts with what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7784686$23C9576D-0665-42E4-B905-78BFD67D7C61",
    "theme": "ChemicalCompound",
    "subject_label": "thioperamide",
    "subject_id": "Q7784686",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Histamine receptor H3",
    "object_id": "Q288395",
    "context": "Thioperamide interacts physically with histamine receptor H3.",
    "propertyCQ": "How does thioperamide interact with histamine receptor H3?",
    "objectCQ": "Thioperamide interacts physically with what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q407426$64455096-FE27-4691-8BB8-E89AF291DBF4",
    "theme": "ChemicalCompound",
    "subject_label": "linoleic acid",
    "subject_id": "Q407426",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Hepatocyte nuclear factor 4 alpha",
    "object_id": "Q21114166",
    "context": "Linoleic acid interacts physically with the Hepatocyte nuclear factor 4 alpha.",
    "propertyCQ": "How does linoleic acid interact with the Hepatocyte nuclear factor 4 alpha?",
    "objectCQ": "What does linoleic acid interact with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q6004821$0060844F-7043-461B-80D7-AE9D294BCE73",
    "theme": "ChemicalCompound",
    "subject_label": "Immepip",
    "subject_id": "Q6004821",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Histamine receptor H3",
    "object_id": "Q288395",
    "context": "Immepip interacts physically with the Histamine receptor H3.",
    "propertyCQ": "How does Immepip interact with the Histamine receptor?",
    "objectCQ": "What does Immepip interact with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q223068$A9BC1F9C-1122-4972-A2C4-F9D1DB42A472",
    "theme": "ChemicalCompound",
    "subject_label": "3-quinuclidinyl-benzilate",
    "subject_id": "Q223068",
    "property_label": "physically interacts with",
    "property_id": "P129",
    "object_label": "Cholinergic receptor muscarinic 4",
    "object_id": "Q4847907",
    "context": "3-quinuclidinyl-benzilate interacts physically with the Cholinergic receptor muscarinic 4.",
    "propertyCQ": "How does 3-quinuclidinyl-benzilate interact with the Cholinergic receptor?",
    "objectCQ": "What does 3-quinuclidinyl-benzilate interact with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q251347$F8E3B9A9-4CA9-4FB7-B17E-B0011776B7CB",
    "theme": "ChemicalCompound",
    "subject_label": "haloperidol",
    "subject_id": "Q251347",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "anxiety",
    "object_id": "Q154430",
    "context": "Haloperidol is a medical condition treated with anxiety.",
    "propertyCQ": "What is haloperidol?",
    "objectCQ": "What is Haloperidol treated with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q411325$DD0AB3BE-852C-48CC-B03D-E6C1FCF73436",
    "theme": "ChemicalCompound",
    "subject_label": "atenolol",
    "subject_id": "Q411325",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "ventricular fibrillation",
    "object_id": "Q848662",
    "context": "Atenolol is used to treat ventricular fibrillation.",
    "propertyCQ": "What is ventricular fibrillation?",
    "objectCQ": "What is Atenolol used to treat?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q241150$1B3561EB-FECB-461E-B024-4C0C58AE8FE7",
    "theme": "ChemicalCompound",
    "subject_label": "aminoglutethimide",
    "subject_id": "Q241150",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "breast cancer",
    "object_id": "Q128581",
    "context": "The medical condition of breast cancer is treated with aminoglutethimide.",
    "propertyCQ": "What is aminoglutethimide used for?",
    "objectCQ": "What is treated with aminoglutethimide?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q417555$476547F5-383E-4248-A622-57AC32A6898C",
    "theme": "ChemicalCompound",
    "subject_label": "teniposide",
    "subject_id": "Q417555",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "lymphoblastic leukemia",
    "object_id": "Q18553852",
    "context": "Teniposide is a medical condition treated by lymphoblastic leukemia.",
    "propertyCQ": "What is teniposide?",
    "objectCQ": "What is the medical condition that treats teniposide?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q408471$733B240F-0A0E-4FC7-9471-79B6B13A12AD",
    "theme": "ChemicalCompound",
    "subject_label": "paroxetine",
    "subject_id": "Q408471",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "anxiety disorder",
    "object_id": "Q544006",
    "context": "Anxiety disorder is a medical condition treated with paroxetine.",
    "propertyCQ": "What is anxiety disorder?",
    "objectCQ": "What is a medical condition treated with paroxetine?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q244150$471F7BDB-B7F2-41BB-B2AB-C6785187B7F9",
    "theme": "ChemicalCompound",
    "subject_label": "ampicillin",
    "subject_id": "Q244150",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "staphylococcal infection",
    "object_id": "Q34879",
    "context": "The medical condition of ampicillin is staphylococcal infection.",
    "propertyCQ": "What is staphylococcal infection?",
    "objectCQ": "What is the medical condition of ampicillin?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q412443$3B7D6613-B4F6-4A70-8442-36B00023FB13",
    "theme": "ChemicalCompound",
    "subject_label": "risperidone",
    "subject_id": "Q412443",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "oppositional defiant disorder",
    "object_id": "Q1328833",
    "context": "Risperidone is used to treat the oppositional defiant disorder.",
    "propertyCQ": "What is oppositional defiant disorder?",
    "objectCQ": "What is Risperidone used to treat?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3151081$3843CB4B-DC4D-4D70-B4A9-5C52B4AEA42C",
    "theme": "ChemicalCompound",
    "subject_label": "filgrastim",
    "subject_id": "Q3151081",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "acute myeloid leukemia",
    "object_id": "Q264118",
    "context": "The medical condition of filgrastim is acute myeloid leukemia.",
    "propertyCQ": "What is filgrastim?",
    "objectCQ": "What is the medical condition of filgrastim?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q3896970$A5EFFD11-740B-4610-A93F-E0A37E82C1EE",
    "theme": "ChemicalCompound",
    "subject_label": "Pasireotide",
    "subject_id": "Q3896970",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "pituitary-dependent Cushing's disease",
    "object_id": "Q11312280",
    "context": "Pasireotide is a medical condition treated with pituitary-dependent Cushing's disease.",
    "propertyCQ": "What is Pasireotide?",
    "objectCQ": "What is the medical condition Pasireotide treated with?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q413762$285B2A0D-4BB3-4282-BFC6-45D875B414F1",
    "theme": "ChemicalCompound",
    "subject_label": "Hyoscyamine",
    "subject_id": "Q413762",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "tremor",
    "object_id": "Q223907",
    "context": "Hyoscyamine is used to treat tremors.",
    "propertyCQ": "What is hyoscyamine used for?",
    "objectCQ": "What is hyoscyamine used to treat?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425386$6DFA3706-C19A-48A7-A346-852A3EBB30B3",
    "theme": "ChemicalCompound",
    "subject_label": "dyclonine",
    "subject_id": "Q425386",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "pain",
    "object_id": "Q81938",
    "context": "Dyclonine is used to treat pain.",
    "propertyCQ": "What is Dyclonine used for?",
    "objectCQ": "What is Dyclonine used to treat?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q408283$5A1E4860-1A87-4D3F-8E91-C77C626C3D2E",
    "theme": "ChemicalCompound",
    "subject_label": "denosumab",
    "subject_id": "Q408283",
    "property_label": "medical condition treated",
    "property_id": "P2175",
    "object_label": "rare breast tumor",
    "object_id": "Q55785783",
    "context": "Denosumab is used to treat a rare breast tumor.",
    "propertyCQ": "What is Denosumab used for?",
    "objectCQ": "What is Denosumab used to treat?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q56047788$7C37FFB7-792B-455F-8F53-10E5713902BC",
    "theme": "ChemicalCompound",
    "subject_label": "Pharmacology of MDMA in Humans",
    "subject_id": "Q56047788",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "de la Torre R",
    "object_id": "",
    "context": "The author name of Pharmacology of MDMA in Humans is de la Torre R.",
    "propertyCQ": "What is the author name of Pharmacology of MDMA in Humans?",
    "objectCQ": "What is the author name of Pharmacology of MDMA in Humans?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37351168$E598875E-3749-4D73-9E7B-BE2A518715A2",
    "theme": "ChemicalCompound",
    "subject_label": "The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention.",
    "subject_id": "Q37351168",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Andy C Parrott",
    "object_id": "",
    "context": "The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention. The author name is Andy C Parrott.",
    "propertyCQ": "What is Andy C Parrott's last name?",
    "objectCQ": "Who is the author of this article?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q40940013$6BD007D2-479D-4A47-B291-8D5A8B937B16",
    "theme": "ChemicalCompound",
    "subject_label": "Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA.",
    "subject_id": "Q40940013",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Carla Escobar-Valero",
    "object_id": "",
    "context": "Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA. The author name is Carla Escobar-Valero.",
    "propertyCQ": "What is the author name of the study?",
    "objectCQ": "Who is the author of this study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q93921863$CAF40CF3-3F0B-4986-A4F1-EA920F419D71",
    "theme": "ChemicalCompound",
    "subject_label": "Toxic effect of MDMA on brain serotonin neurons",
    "subject_id": "Q93921863",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "A Klugman",
    "object_id": "",
    "context": "A Klugman is the author of Toxic effect of MDMA on brain serotonin neurons.",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "Who is the author of Toxic effect of MDMA on brain serotonin neurons?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q47731855$1BB44EA1-6BF9-4FC9-A721-4E6863AEBC00",
    "theme": "ChemicalCompound",
    "subject_label": "Oxytocin and MDMA ('Ecstasy') enhance social reward in rats.",
    "subject_id": "Q47731855",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Alex Caminer",
    "object_id": "",
    "context": "Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. The author name is Alex Caminer.",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "What is the author name of Ecstasy?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q43118935$DD04D2AE-C587-45F6-9A1C-9E9286981C93",
    "theme": "ChemicalCompound",
    "subject_label": "Factor structure of the Chinese version of the University of Rhode Island change assessment in Taiwanese adolescents who abuse MDMA or methamphetamine.",
    "subject_id": "Q43118935",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Ya-Shune Huang",
    "object_id": "",
    "context": "Ya-Shune Huang is the author of Factor structure of the Chinese version of the University of Rhode Island change assessment in Taiwanese adolescents who abuse MDMA or methamphetamine.",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "Who is the author of Factor structure of the Chinese version of the University of Rhode Island change assessment?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q28365378$9984ED04-3A7A-4082-9F00-C6412B3AFC9E",
    "theme": "ChemicalCompound",
    "subject_label": "In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA",
    "subject_id": "Q28365378",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "G J McBean",
    "object_id": "",
    "context": "G J McBean is the author of In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA.",
    "propertyCQ": "What is the name of the author of In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA?",
    "objectCQ": "Who is the author of In vitro neuronal and vascular responses to 5-HT in rats chronically exposed to MDMA?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q43291477$2AA30705-CC74-4311-8561-943208AB5B2F",
    "theme": "ChemicalCompound",
    "subject_label": "Chronic exposure to MDMA (ecstasy) increases DNA damage in sperm and alters testes histopathology in male rats.",
    "subject_id": "Q43291477",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Miguel Rodamilans",
    "object_id": "",
    "context": "The author name of the book is Miguel Rodamilans and the exposure to MDMA (ecstasy) increases DNA damage in sperm and alters testes histopathology in male rats.",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "What is the author name of the book?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q51807530$EFB11733-6D18-4FAF-9C8E-BCFC78011397",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.",
    "subject_id": "Q51807530",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "J M Llobet",
    "object_id": "",
    "context": "J M Llobet is the author of Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro.",
    "propertyCQ": "What is the name of the author of Effects of MDMA?",
    "objectCQ": "Who is the author of Effects of MDMA and two of its metabolites on rat embryos in vitro?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37392237$71D5A59E-F9F1-4B4C-8331-314BE1E4A4BF",
    "theme": "ChemicalCompound",
    "subject_label": "Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.",
    "subject_id": "Q37392237",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "P McKinney",
    "object_id": "",
    "context": "P McKinney is the author of Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats.",
    "propertyCQ": "What is the author name of the book?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q58283924$D14FE1A0-40A1-46F1-BA94-31F14982E28C",
    "theme": "ChemicalCompound",
    "subject_label": "Validating the Consumption of Mdma (3,4- Methylenedioxymethamphetamine) in an Examination of the Behavioural Effects of “Ecstasy” Amongst Recreational Users",
    "subject_id": "Q58283924",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Kim Wolff",
    "object_id": "",
    "context": "Kim Wolff is the author of \"Validating the Consumption of Mdma (3,4- Methylenedioxymethamphetamine) in an Examination of the Behavioural Effects of \"Ecstasy\" Amongst Recreational Users\".",
    "propertyCQ": "What is the name of Kim Wolff?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q44471968$411BF350-8EBE-4DFC-A6C6-88A1623E8B6E",
    "theme": "ChemicalCompound",
    "subject_label": "3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative stress and potential free radical damage.",
    "subject_id": "Q44471968",
    "property_label": "author name string",
    "property_id": "P2093",
    "object_label": "Liang Zhang",
    "object_id": "",
    "context": "Liang Zhang is the author of 3,4-Methylenedioxymethamphetamine (MDMA), which can cause oxidative stress and potential free radical damage.",
    "propertyCQ": "What is the name of the author of MDMA?",
    "objectCQ": "Who is the author of MDMA?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q1810456$FAAE10C4-BBEA-49BA-95E6-8465C31D73CE",
    "theme": "ChemicalCompound",
    "subject_label": "Carbadox",
    "subject_id": "Q1810456",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "mutagen",
    "object_id": "Q221696",
    "context": "Carbadox is a mutagen.",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is carbadox?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q21099650$3FBB8134-BDA3-4DF9-9368-A42D6FB7987C",
    "theme": "ChemicalCompound",
    "subject_label": "1-hydroxypyrene",
    "subject_id": "Q21099650",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "mutagen",
    "object_id": "Q221696",
    "context": "1-hydroxypyrene is a mutagen.",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is 1-hydroxypyrene?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27075614$7E192F17-F8AA-4ED1-9595-7FC8F5283486",
    "theme": "ChemicalCompound",
    "subject_label": "3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate",
    "subject_id": "Q27075614",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "platelet aggregation inhibitors",
    "object_id": "Q721432",
    "context": "3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate is a subject that has a role as platelet aggregation inhibitors.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q421475$C6CF0FC0-3FAD-49A7-9614-1D454D98E5D9",
    "theme": "ChemicalCompound",
    "subject_label": "beclomethasone dipropionate",
    "subject_id": "Q421475",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "anti-inflammatory agent",
    "object_id": "Q581996",
    "context": "Beclomethasone dipropionate is an anti-inflammatory agent.",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is beclomethasone dipropionate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q414873$60554B6B-6A86-4E53-B712-B7FA6FB9ED93",
    "theme": "ChemicalCompound",
    "subject_label": "isradipine",
    "subject_id": "Q414873",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "vasodilator agent",
    "object_id": "Q4008956",
    "context": "Isradipine is a vasodilator agent.",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is isradipine?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425097$472ED0E9-57F4-4999-97C5-9CC160F182E1",
    "theme": "ChemicalCompound",
    "subject_label": "acepromazine",
    "subject_id": "Q425097",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "antipsychotics",
    "object_id": "Q208144",
    "context": "Acepromazine has a role in antipsychotics.",
    "propertyCQ": "What does acepromazine do?",
    "objectCQ": "What is Acepromazine used for?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q10861380$9503B5E1-7ADC-436F-9984-5588BAE3E047",
    "theme": "ChemicalCompound",
    "subject_label": "Sudan Black B",
    "subject_id": "Q10861380",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "dye",
    "object_id": "Q189720",
    "context": "The subject of Sudan Black B has a role in the use of dye.",
    "propertyCQ": "What does Sudan Black B have in the use of dye?",
    "objectCQ": "What does Sudan Black B have a role in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q5210829$8B9F8E35-3C7C-4FC0-8851-EA8338A11A9D",
    "theme": "ChemicalCompound",
    "subject_label": "dalfopristin",
    "subject_id": "Q5210829",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "antibiotic",
    "object_id": "Q12187",
    "context": "Dalfopristin is an antibiotic.",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is Dalfopristin?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q423538$810D334E-1C38-4C1E-A783-7AE2A543D9EE",
    "theme": "ChemicalCompound",
    "subject_label": "tizanidine",
    "subject_id": "Q423538",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "central muscle relaxants",
    "object_id": "Q50430093",
    "context": "Tizanidine is a central muscle relaxant.",
    "propertyCQ": "What is the role of Tizanidine?",
    "objectCQ": "What is Tizanidine?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27251372$01583169-AD85-46BD-99E9-ECD6A4DF39EA",
    "theme": "ChemicalCompound",
    "subject_label": "picumast",
    "subject_id": "Q27251372",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "H1 antagonist",
    "object_id": "Q1328275",
    "context": "H1 antagonist is a role in picumast.",
    "propertyCQ": "What is H1 antagonist?",
    "objectCQ": "What is a role in picumast?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2013780$9B5F422C-70C0-42B7-92E6-3BF025C2259B",
    "theme": "ChemicalCompound",
    "subject_label": "Ocrelizumab",
    "subject_id": "Q2013780",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "immunologic factor",
    "object_id": "Q50349184",
    "context": "Ocrelizumab has a role in the immunologic factor.",
    "propertyCQ": "What does Ocrelizumab do to the immunologic factor?",
    "objectCQ": "What does Ocrelizumab play a role in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q423439$DE0D3DB6-C29E-4542-948D-25C110D14220",
    "theme": "ChemicalCompound",
    "subject_label": "cerivastatin",
    "subject_id": "Q423439",
    "property_label": "subject has role",
    "property_id": "P2868",
    "object_label": "statin",
    "object_id": "Q954845",
    "context": "Cerivastatin is a statin.",
    "propertyCQ": "What is the role of the subject?",
    "objectCQ": "What is Cerivastatin?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2467410$83900029-74FA-410E-96D5-F3BA47210A67",
    "theme": "ChemicalCompound",
    "subject_label": "tropine",
    "subject_id": "Q2467410",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "63.0 degree Celsius",
    "object_id": "",
    "context": "The melting point of tropine is 63.0 degrees Celsius.",
    "propertyCQ": "What is the melting point of tropine?",
    "objectCQ": "What is the melting point of tropine?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72489527$A147D508-76FD-4699-885B-E21216670CB7",
    "theme": "ChemicalCompound",
    "subject_label": "2-(Methoxycarbonyl)phenyl isocyanate",
    "subject_id": "Q72489527",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "47.0 degree Celsius",
    "object_id": "",
    "context": "2-(Methoxycarbonyl)phenyl isocyanate has a melting point of 47 degrees Celsius.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q906080$bb5e1932-4d67-cdb3-5e89-e8c5c7e702a7",
    "theme": "ChemicalCompound",
    "subject_label": "Chrysolaminarin",
    "subject_id": "Q906080",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "273 degree Celsius",
    "object_id": "",
    "context": "Chrysolaminarin has a melting point of 273 degree Celsius.",
    "propertyCQ": "What is Chrysolaminarin's degree Celsius?",
    "objectCQ": "What is Chrysolaminarin's melting point?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q11186388$EA57AC15-90C7-4ACB-B22F-B520FC1FEB76",
    "theme": "ChemicalCompound",
    "subject_label": "2,3-hexanedione",
    "subject_id": "Q11186388",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "-30.0 degree Celsius",
    "object_id": "",
    "context": "2,3-hexanedione has a melting point of -30.0 degree Celsius.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72451205$6E75210C-EA4E-49C8-89C4-2F972B8EE5DB",
    "theme": "ChemicalCompound",
    "subject_label": "2-Bromoacetamide",
    "subject_id": "Q72451205",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "89.0 degree Celsius",
    "object_id": "",
    "context": "2-Bromoacetamide has a melting point of 89.0 degree Celsius.",
    "propertyCQ": "What is 2-Bromoacetamide's degree Celsius?",
    "objectCQ": "What is the melting point of 2-Bromoacetamide?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q26421079$D9E31202-93B8-4E8F-8FC6-77E8056576E3",
    "theme": "ChemicalCompound",
    "subject_label": "O-bromophenol",
    "subject_id": "Q26421079",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "5.0 degree Celsius",
    "object_id": "",
    "context": "O-bromophenol has a melting point of 5.0 degree Celsius.",
    "propertyCQ": "What is the melting point of O-bromophenol?",
    "objectCQ": "What is the melting point of O-bromophenol?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72467701$55A48ACB-6A17-45B9-B461-FA48796EEA9D",
    "theme": "ChemicalCompound",
    "subject_label": "2,4-Dimethoxybenzyl alcohol",
    "subject_id": "Q72467701",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "37.0 degree Celsius",
    "object_id": "",
    "context": "2,4-Dimethoxybenzyl alcohol has a melting point of 37 degrees Celsius.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q69999956$A2D8A3F9-1748-4132-8681-DEB71E76AC3D",
    "theme": "ChemicalCompound",
    "subject_label": "5-bromo-2-(tert-butoxy)pyrimidine",
    "subject_id": "Q69999956",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "62.0 degree Celsius",
    "object_id": "",
    "context": "5-bromo-2-(tert-butoxy)pyrimidine has a melting point of 62.0 degree Celsius.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72443622$F195B721-3BDE-414D-88BD-E505F994D253",
    "theme": "ChemicalCompound",
    "subject_label": "4-Biphenylacetonitrile",
    "subject_id": "Q72443622",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "95.0 degree Celsius",
    "object_id": "",
    "context": "4-Biphenylacetonitrile has a melting point of 95 degrees Celsius.",
    "propertyCQ": "What is 4-Biphenylacetonitrile's temperature?",
    "objectCQ": "What is 4-Biphenylacetonitrile's melting point?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q72441562$B8C3AD26-E49A-453B-8E27-1CE5C8B03C6C",
    "theme": "ChemicalCompound",
    "subject_label": "5-Amino-2-pyridinecarboxylic acid",
    "subject_id": "Q72441562",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "218.0 degree Celsius",
    "object_id": "",
    "context": "5-Amino-2-pyridinecarboxylic acid has a melting point of 218.0 degree Celsius.",
    "propertyCQ": "What degree Celsius does 5-Amino-2-pyridinecarboxylic acid have?",
    "objectCQ": "What is the melting point of 5-Amino-2-pyridinecarboxylic acid?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q225045$a5163dd8-46c4-22dd-69be-f35e7a5243ec",
    "theme": "ChemicalCompound",
    "subject_label": "carbon tetrachloride",
    "subject_id": "Q225045",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "-22.6 degree Celsius",
    "object_id": "",
    "context": "The melting point of carbon tetrachloride is -22.6 degree Celsius.",
    "propertyCQ": "What is the melting point of carbon tetrachloride?",
    "objectCQ": "What is the melting point of carbon tetrachloride?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27261970$468D1AB4-EC6F-48A3-B5F1-B44D709D6BA4",
    "theme": "ChemicalCompound",
    "subject_label": "2-(methanesulfonyl)ethanol",
    "subject_id": "Q27261970",
    "property_label": "melting point",
    "property_id": "P2101",
    "object_label": "29.0 degree Celsius",
    "object_id": "",
    "context": "2-(methanesulfonyl)ethanol has a melting point of 29.0 degree Celsius.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594730$DEA36E59-384E-4210-9EED-E0A1895A7C35",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-378h",
    "subject_id": "Q27594730",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 5",
    "object_id": "Q840741",
    "context": "Hsa-miR-378h is a human chromosome 5.",
    "propertyCQ": "What part of the human genome is Hsa-miR-378h?",
    "objectCQ": "What is Hsa-miR-378h?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068514$BF3C5084-83A6-4241-B177-EC9A84F92054",
    "theme": "ChemicalCompound",
    "subject_label": "MIR4483",
    "subject_id": "Q18068514",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 10",
    "object_id": "Q840737",
    "context": "MIR4483 is the chromosome of human chromosome 10.",
    "propertyCQ": "What part of the human genome is MIR4483?",
    "objectCQ": "What is MIR4483 the chromosome of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591938$254610D9-1548-4457-AF51-4970EF0FB03C",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-941-3",
    "subject_id": "Q27591938",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 20",
    "object_id": "Q666752",
    "context": "The human chromosome 20 is the chromosome of hsa-mir-941-3.",
    "propertyCQ": "What part of the human genome is hsa-mir-941-3?",
    "objectCQ": "What is the chromosome of hsa-mir-941-3?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594558$482078E9-4371-4DEF-BD44-430814484B40",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-4789-3p",
    "subject_id": "Q27594558",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 3",
    "object_id": "Q668633",
    "context": "Hsa-miR-4789-3p is a human chromosome 3.",
    "propertyCQ": "What part of the body is Hsa-miR-4789-3p?",
    "objectCQ": "What is Hsa-miR-4789-3p?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068005$16F4B6D1-7EC3-40B9-8620-27DEE3943D21",
    "theme": "ChemicalCompound",
    "subject_label": "SPTY2D1OS",
    "subject_id": "Q18068005",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 11",
    "object_id": "Q847096",
    "context": "The human chromosome 11 is the chromosome of SPTY2D1OS.",
    "propertyCQ": "What part of the human genome is SPTY2D1OS?",
    "objectCQ": "What is the chromosome of SPTY2D1OS?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q66659415$6B27D3E2-A447-4E8A-ACCB-D41A5C1AA5CB",
    "theme": "ChemicalCompound",
    "subject_label": "Gm24389",
    "subject_id": "Q66659415",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "mouse chromosome 17",
    "object_id": "Q15305616",
    "context": "The mouse chromosome 17 is the chromosome of Gm24389.",
    "propertyCQ": "What part of the genome is Gm24389?",
    "objectCQ": "What is the chromosome of Gm24389?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18058045$01B0AF94-F6D0-44B5-B59C-F6D50C1D97B2",
    "theme": "ChemicalCompound",
    "subject_label": "MIR134",
    "subject_id": "Q18058045",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 14",
    "object_id": "Q138955",
    "context": "The human chromosome 14 is the MIR134 chromosome.",
    "propertyCQ": "What is the MIR134?",
    "objectCQ": "What is the MIR134 chromosome?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q66667542$F5E1380C-EE0F-4E29-A2DE-9A788A9CD458",
    "theme": "ChemicalCompound",
    "subject_label": "Gm23795",
    "subject_id": "Q66667542",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "mouse chromosome 7",
    "object_id": "Q15305579",
    "context": "The mouse chromosome 7 is the chromosome of Gm23795.",
    "propertyCQ": "What part of the genome is Gm23795?",
    "objectCQ": "What is the chromosome of Gm23795?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q56473182$F63FB8B9-D8C6-4DD8-B838-3244CA8266CC",
    "theme": "ChemicalCompound",
    "subject_label": "uncharacterized LOC107382577",
    "subject_id": "Q56473182",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "Nothobranchius furzeri chromosome sgr08",
    "object_id": "Q56419076",
    "context": "The chromosome of Nothobranchius furzeri is sgr08 and is uncharacterized by LOC107382577.",
    "propertyCQ": "What part of Nothobranchius furzeri is uncharacterized by LOC107382577?",
    "objectCQ": "What is the chromosome of Nothobranchius furzeri?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18075242$B1E73FE3-7A25-44C3-8D4F-C943729F1665",
    "theme": "ChemicalCompound",
    "subject_label": "MIR6806",
    "subject_id": "Q18075242",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 19",
    "object_id": "Q510786",
    "context": "The human chromosome 19 is the chromosome MIR6806.",
    "propertyCQ": "What is the MIR6806?",
    "objectCQ": "What is the chromosome MIR6806?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20778046$27EEE89C-45E1-4316-9563-3BA6B7197F2E",
    "theme": "ChemicalCompound",
    "subject_label": "LINC02444",
    "subject_id": "Q20778046",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 12",
    "object_id": "Q847102",
    "context": "LINC02444 is the chromosome 12 of the human.",
    "propertyCQ": "What part of the human genome is LINC02444?",
    "objectCQ": "What is LINC02444?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592876$A1743F2E-09C1-4DC0-B2EC-7C16FBAFC026",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-4424",
    "subject_id": "Q27592876",
    "property_label": "chromosome",
    "property_id": "P1057",
    "object_label": "human chromosome 1",
    "object_id": "Q430258",
    "context": "Hsa-miR-4424 is a human chromosome.",
    "propertyCQ": "What is Hsa-miR-4424?",
    "objectCQ": "What is Hsa-miR-4424?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18069434$00ECE410-7819-4F6A-B4F3-97EDD85F4A38",
    "theme": "ChemicalCompound",
    "subject_label": "MIR5584",
    "subject_id": "Q18069434",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "context": "MIR5584 has a forward strand orientation.",
    "propertyCQ": "What does MIR5584 have?",
    "objectCQ": "What orientation does MIR5584 have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594686$0D24069A-FDC9-4CC5-B42F-4B53513C719E",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-582-3p",
    "subject_id": "Q27594686",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "context": "Hsa-miR-582-3p has a reverse strand orientation.",
    "propertyCQ": "What is the reverse of the Hsa-miR-582-3p?",
    "objectCQ": "What orientation does the Hsa-miR-582-3p have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18080800$14BEC6F7-FDEA-4950-AE32-BBD7CEFB45E9",
    "theme": "ChemicalCompound",
    "subject_label": "MIR8053",
    "subject_id": "Q18080800",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "context": "MIR8053 has a forward strand orientation.",
    "propertyCQ": "What does MIR8053 have?",
    "objectCQ": "What orientation does MIR8053 have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q24422494$824D3CF5-4B27-439F-AE6A-D1010091FA44",
    "theme": "ChemicalCompound",
    "subject_label": "Mir872",
    "subject_id": "Q24422494",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "context": "Mir872 has a forward strand orientation.",
    "propertyCQ": "What is the forward orientation of the Mir872?",
    "objectCQ": "What is the orientation of the Mir872?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592523$82C7D0F7-266E-4220-B10A-EC64476492EF",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-3651",
    "subject_id": "Q27592523",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "context": "Hsa-mir-3651 has a reverse strand orientation.",
    "propertyCQ": "What is the reverse of the Hsa-mir-3651?",
    "objectCQ": "What orientation does Hsa-mir-3651 have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18062515$D447CA2A-DBD4-4188-B39B-7462FB4B9AE4",
    "theme": "ChemicalCompound",
    "subject_label": "MIR541",
    "subject_id": "Q18062515",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "context": "MIR541 has a forward strand orientation.",
    "propertyCQ": "What does MIR541 have?",
    "objectCQ": "What orientation does MIR541 have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068076$E8562332-27E1-4104-B305-FA91357C22F5",
    "theme": "ChemicalCompound",
    "subject_label": "CFAP100-DT",
    "subject_id": "Q18068076",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "context": "The CFAP100-DT has a reverse strand orientation.",
    "propertyCQ": "What is the reverse orientation of the CFAP100-DT?",
    "objectCQ": "What orientation does the CFAP100-DT have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27595280$FBFE19FC-103D-46C5-983E-94110AFB2589",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-19b-2-5p",
    "subject_id": "Q27595280",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "context": "Hsa-miR-19b-2-5p has a reverse strand orientation.",
    "propertyCQ": "What is reversed in Hsa-miR-19b-2-5p?",
    "objectCQ": "What orientation does Hsa-miR-19b-2-5p have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18311739$6953C7A9-EACA-4F3D-B1BE-C3A9C2D1495C",
    "theme": "ChemicalCompound",
    "subject_label": "Mir429",
    "subject_id": "Q18311739",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "context": "Mir429 has a reverse strand orientation.",
    "propertyCQ": "What is the reverse of the Mir429?",
    "objectCQ": "What type of orientation does Mir429 have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20782118$479A1419-908E-4023-AEC6-FF88320985CF",
    "theme": "ChemicalCompound",
    "subject_label": "BISPR",
    "subject_id": "Q20782118",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "context": "BISPR's strand orientation is forward strand.",
    "propertyCQ": "What is forward strand?",
    "objectCQ": "What is BISPR's strand orientation?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592382$DDCD3C9A-52EE-4ADB-9A31-2808EDF47E68",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-4467",
    "subject_id": "Q27592382",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "forward strand",
    "object_id": "Q22809680",
    "context": "Hsa-mir-4467 has a forward strand orientation.",
    "propertyCQ": "What is Hsa-mir-4467's forward orientation?",
    "objectCQ": "What orientation does Hsa-mir-4467 have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18054355$5FFEFAA9-BA3B-4D8D-8996-C752253B2062",
    "theme": "ChemicalCompound",
    "subject_label": "RUSC1-AS1",
    "subject_id": "Q18054355",
    "property_label": "strand orientation",
    "property_id": "P2548",
    "object_label": "reverse strand",
    "object_id": "Q22809711",
    "context": "RUSC1-AS1 has a reverse strand orientation.",
    "propertyCQ": "What is reversed on RUSC1-AS1?",
    "objectCQ": "What orientation does RUSC1-AS1 have?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18075140$47666F76-D3F5-4963-96A9-330CBE2BABD6",
    "theme": "ChemicalCompound",
    "subject_label": "MIR6740",
    "subject_id": "Q18075140",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "202003124",
    "object_id": "",
    "context": "The genomic start date for MIR6740 is 202003124.",
    "propertyCQ": "What is the start date for MIR6740?",
    "objectCQ": "What is the genomic start date for MIR6740?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068758$605C1828-A4BF-412F-A538-0BC89691F2C3",
    "theme": "ChemicalCompound",
    "subject_label": "MIR548AE2",
    "subject_id": "Q18068758",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "57825870",
    "object_id": "",
    "context": "MIR548AE2 has a genomic start of 57825870.",
    "propertyCQ": "What is the start of MIR548AE2?",
    "objectCQ": "What is the genomic start of MIR548AE2?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591483$2B18B226-DDCD-4948-AED2-4DC9FD27F38F",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-6129",
    "subject_id": "Q27591483",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "49288346",
    "object_id": "",
    "context": "Hsa-mir-6129 has a genomic start of 49288346.",
    "propertyCQ": "What is the start of Hsa-mir-6129?",
    "objectCQ": "What is the genomic start of Hsa-mir-6129?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18062569$B316E36A-8352-4D1C-BD5D-F8281C8C9FA3",
    "theme": "ChemicalCompound",
    "subject_label": "GHRLOS",
    "subject_id": "Q18062569",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "10327438",
    "object_id": "",
    "context": "The genomic start of GHRLOS is 10327438.",
    "propertyCQ": "What is the name of the start of GHRLOS?",
    "objectCQ": "What is the genomic start of GHRLOS?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068196$14F471A0-56D2-41BF-AFE0-E322400F8747",
    "theme": "ChemicalCompound",
    "subject_label": "EGFR-AS1",
    "subject_id": "Q18068196",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "55247443",
    "object_id": "",
    "context": "EGFR-AS1 has a genomic start of 55247443.",
    "propertyCQ": "What is the start of EGFR-AS1?",
    "objectCQ": "What is the genomic start of EGFR-AS1?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591287$EE2B2756-6B3E-4BC3-A474-75C3512CD7CA",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-7973-2",
    "subject_id": "Q27591287",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "51314032",
    "object_id": "",
    "context": "Hsa-mir-7973-2 has a genomic start of 51314032.",
    "propertyCQ": "What is the start of Hsa-mir-7973-2?",
    "objectCQ": "What is the genomic start of Hsa-mir-7973-2?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18319209$5C7FC9B1-CAAE-4A75-B76C-0070A33889F4",
    "theme": "ChemicalCompound",
    "subject_label": "Mir1192",
    "subject_id": "Q18319209",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "23149431",
    "object_id": "",
    "context": "Mir1192 has a genomic start of 23149431.",
    "propertyCQ": "What is Mir1192's unique start?",
    "objectCQ": "Mir1192 has a genomic start of what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591995$35EF5C72-E969-4D6B-A845-454EBA712431",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-7109",
    "subject_id": "Q27591995",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "31621467",
    "object_id": "",
    "context": "Hsa-mir-7109 has a genomic start of 31621467.",
    "propertyCQ": "What is the start number of Hsa-mir-7109?",
    "objectCQ": "What is the genomic start of Hsa-mir-7109?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20869784$3791801B-B7E8-472A-96A2-F5A4E9822B55",
    "theme": "ChemicalCompound",
    "subject_label": "Gm40418",
    "subject_id": "Q20869784",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "50120309",
    "object_id": "",
    "context": "The genomic start of Gm40418 is 50120309.",
    "propertyCQ": "What is the start number of Gm40418?",
    "objectCQ": "What is the genomic start of Gm40418?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20775423$05AD94DE-D2BC-4FF3-879F-69130148629A",
    "theme": "ChemicalCompound",
    "subject_label": "MIR3182",
    "subject_id": "Q20775423",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "83508346",
    "object_id": "",
    "context": "MIR3182 has a genomic start of 83508346.",
    "propertyCQ": "What is the start of MIR3182?",
    "objectCQ": "What is the genomic start of MIR3182?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50384340$7817012E-F39D-452C-A10B-9BFF58F5FC24",
    "theme": "ChemicalCompound",
    "subject_label": "tRNA-Asp encoded by: aspV b0216",
    "subject_id": "Q50384340",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "236930",
    "object_id": "",
    "context": "TRNA-Asp is encoded by: aspV b0216 and has a genomic start of 236930.",
    "propertyCQ": "What is the start of TRNA-Asp?",
    "objectCQ": "What is the genomic start of TRNA-Asp?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593435$95BEBE88-DDB8-4314-9162-AFF64D8A489F",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1193",
    "subject_id": "Q27593435",
    "property_label": "genomic start",
    "property_id": "P644",
    "object_label": "101030061",
    "object_id": "",
    "context": "Hsa-miR-1193 has a genomic start of 101030061.",
    "propertyCQ": "What is the start of Hsa-miR-1193?",
    "objectCQ": "What is the genomic start of Hsa-miR-1193?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18075140$ADF91ACB-1EE4-4EF6-AFC8-D78CAF84EC1D",
    "theme": "ChemicalCompound",
    "subject_label": "MIR6740",
    "subject_id": "Q18075140",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "202003236",
    "object_id": "",
    "context": "The genomic end of MIR6740 is 202003236.",
    "propertyCQ": "What is the end of MIR6740?",
    "objectCQ": "What is the genomic end of MIR6740?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068758$70766C8C-B16C-47B0-8D91-2F8BB16C9B73",
    "theme": "ChemicalCompound",
    "subject_label": "MIR548AE2",
    "subject_id": "Q18068758",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "57825936",
    "object_id": "",
    "context": "The genomic end of MIR548AE2 is 57825936.",
    "propertyCQ": "What is the end of MIR548AE2?",
    "objectCQ": "What is the genomic end of MIR548AE2?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591483$996FAB23-EF48-46A5-BC84-BD0BAF1AD1D8",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-6129",
    "subject_id": "Q27591483",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "49288454",
    "object_id": "",
    "context": "The genomic end of hsa-mir-6129 is 49288454.",
    "propertyCQ": "What is the end of hsa-mir-6129?",
    "objectCQ": "What is the genomic end of hsa-mir-6129?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18062569$AD21A721-A94D-42BC-BA93-C35DFE99B4EA",
    "theme": "ChemicalCompound",
    "subject_label": "GHRLOS",
    "subject_id": "Q18062569",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "10335133",
    "object_id": "",
    "context": "The genomic end of GHRLOS is 10335133.",
    "propertyCQ": "What is the end of GHRLOS?",
    "objectCQ": "What is the genomic end of GHRLOS?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068196$051F9A88-D677-47DF-929B-E634865E2CE8",
    "theme": "ChemicalCompound",
    "subject_label": "EGFR-AS1",
    "subject_id": "Q18068196",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "55256627",
    "object_id": "",
    "context": "EGFR-AS1 has a genomic end of 55256627.",
    "propertyCQ": "What is the end of EGFR-AS1?",
    "objectCQ": "What is the genomic end of EGFR-AS1?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591287$D56B01C0-72BF-45C1-ADCE-6F54F01C238D",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-7973-2",
    "subject_id": "Q27591287",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "51314107",
    "object_id": "",
    "context": "Hsa-mir-7973-2 has a genomic end of 51314107.",
    "propertyCQ": "What is the end of Hsa-mir-7973-2?",
    "objectCQ": "What is the genomic end of Hsa-mir-7973-2?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18319209$508419F2-6FB6-4863-8BEA-CB5258A6ABE3",
    "theme": "ChemicalCompound",
    "subject_label": "Mir1192",
    "subject_id": "Q18319209",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "23149551",
    "object_id": "",
    "context": "Mir1192 has a genomic end of 23149551.",
    "propertyCQ": "What is Mir1192's status?",
    "objectCQ": "What is Mir1192's genomic end?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27591995$14A6A0FE-7DAB-4BA2-AFEC-1E524D5881A6",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-mir-7109",
    "subject_id": "Q27591995",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "31621531",
    "object_id": "",
    "context": "The genomic end of hsa-mir-7109 is 31621531.",
    "propertyCQ": "What is the end of hsa-mir-7109?",
    "objectCQ": "What is the genomic end of hsa-mir-7109?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20869784$D7DCE79E-F9A1-4101-B289-77EB0BA60CD9",
    "theme": "ChemicalCompound",
    "subject_label": "Gm40418",
    "subject_id": "Q20869784",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "50145236",
    "object_id": "",
    "context": "The genomic end of Gm40418 is 50145236.",
    "propertyCQ": "What is the end of Gm40418?",
    "objectCQ": "What is the genomic end of Gm40418?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20775423$69FAC0BA-BFF6-43B5-AFC2-5336C51C303D",
    "theme": "ChemicalCompound",
    "subject_label": "MIR3182",
    "subject_id": "Q20775423",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "83508408",
    "object_id": "",
    "context": "The genomic end of MIR3182 is 83508408.",
    "propertyCQ": "What is the end of MIR3182?",
    "objectCQ": "What is the genomic end of MIR3182?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50384340$1FBED83E-1CA0-4705-90CA-9D0B8BC4A4ED",
    "theme": "ChemicalCompound",
    "subject_label": "tRNA-Asp encoded by: aspV b0216",
    "subject_id": "Q50384340",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "237007",
    "object_id": "",
    "context": "TRNA-Asp is encoded by: aspV b0216 and has a genomic end of 237007.",
    "propertyCQ": "What is the end of the TRNA-Asp?",
    "objectCQ": "What is the genomic end of TRNA-Asp?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593435$0E9769BD-3558-49E6-8436-33D28B99ACC7",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1193",
    "subject_id": "Q27593435",
    "property_label": "genomic end",
    "property_id": "P645",
    "object_label": "101030083",
    "object_id": "",
    "context": "Hsa-miR-1193 has a genomic end of 101030083.",
    "propertyCQ": "What is the end of Hsa-miR-1193?",
    "objectCQ": "What is the genomic end of Hsa-miR-1193?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20774881$AE064705-0DF1-420E-8AE5-A9ECBF6EF5FD",
    "theme": "ChemicalCompound",
    "subject_label": "LINC01909",
    "subject_id": "Q20774881",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "Right lobe of liver",
    "object_id": "Q6493472",
    "context": "LINC01909 is expressed in the right lobe of liver.",
    "propertyCQ": "Where is LINC01909 found?",
    "objectCQ": "Where is LINC01909 expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068902$4AA6196B-193B-4BBA-9CD6-F359A1F14C78",
    "theme": "ChemicalCompound",
    "subject_label": "MIR3689E",
    "subject_id": "Q18068902",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "colon",
    "object_id": "Q5982337",
    "context": "MIR3689E is expressed in a colon.",
    "propertyCQ": "How is MIR3689E expressed?",
    "objectCQ": "What is MIR3689E expressed in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068483$FAB41091-1EC7-4F9B-8E8A-D9C77A67CA59",
    "theme": "ChemicalCompound",
    "subject_label": "MIR4507",
    "subject_id": "Q18068483",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "lymph node",
    "object_id": "Q170758",
    "context": "MIR4507 is expressed in the lymph node.",
    "propertyCQ": "Where is MIR4507 found?",
    "objectCQ": "Where is MIR4507 expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18072988$4959726E-4D0C-42D7-BC24-5BAD0C64F743",
    "theme": "ChemicalCompound",
    "subject_label": "LINC01216",
    "subject_id": "Q18072988",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "putamen",
    "object_id": "Q550934",
    "context": "LINC01216 is expressed in putamen.",
    "propertyCQ": "How is LINC01216 expressed?",
    "objectCQ": "What is LINC01216 expressed in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18074963$C14737EA-B3F9-4BAF-85BC-03A6D6B87C6A",
    "theme": "ChemicalCompound",
    "subject_label": "RNVU1-6",
    "subject_id": "Q18074963",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "bone marrow",
    "object_id": "Q546523",
    "context": "RNVU1-6 is expressed in bone marrow.",
    "propertyCQ": "How is RNVU1-6 expressed?",
    "objectCQ": "Where is RNVU1-6 expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20763583$ADB8C2BE-1FEA-47AB-B2A8-447530BB50D4",
    "theme": "ChemicalCompound",
    "subject_label": "GLIS2-AS1",
    "subject_id": "Q20763583",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "brain",
    "object_id": "Q1073",
    "context": "GLIS2-AS1 is expressed in the brain.",
    "propertyCQ": "Where is GLIS2-AS1 expressed?",
    "objectCQ": "Where is GLIS2-AS1 expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18072978$14121994-174C-47BE-BB64-7E339F4E2B43",
    "theme": "ChemicalCompound",
    "subject_label": "HAO2-IT1",
    "subject_id": "Q18072978",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "liver",
    "object_id": "Q9368",
    "context": "HAO2-IT1 is expressed in the liver.",
    "propertyCQ": "Where is HAO2-IT1 expressed?",
    "objectCQ": "Where is HAO2-IT1 expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20762983$E5A080FE-10AC-4765-AADB-C861D09EB035",
    "theme": "ChemicalCompound",
    "subject_label": "LINC02800",
    "subject_id": "Q20762983",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "prostate",
    "object_id": "Q9625",
    "context": "LINC02800 is expressed in the prostate.",
    "propertyCQ": "Where is LINC02800 found?",
    "objectCQ": "Where is LINC02800 expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20774903$211BE4D8-76E9-4D2D-8219-82983CBAE83D",
    "theme": "ChemicalCompound",
    "subject_label": "LOC100130449",
    "subject_id": "Q20774903",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "cerebellar vermis",
    "object_id": "Q3078809",
    "context": "LOC100130449 is expressed in the cerebellar vermis.",
    "propertyCQ": "Where is LOC100130449 found?",
    "objectCQ": "Where is LOC100130449 expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18074244$636E0F6E-E6EA-477E-8C7E-F5FDAEBDEF91",
    "theme": "ChemicalCompound",
    "subject_label": "LINC01163",
    "subject_id": "Q18074244",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "myometrium",
    "object_id": "Q2562472",
    "context": "LINC01163 is expressed in myometrium.",
    "propertyCQ": "Where is LINC01163 found?",
    "objectCQ": "Where is LINC01163 expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q21180051$FE6C9AB3-8D48-42F4-ACF9-291E80A02418",
    "theme": "ChemicalCompound",
    "subject_label": "MIR3677HG",
    "subject_id": "Q21180051",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "hippocampus proper",
    "object_id": "Q7308967",
    "context": "MIR3677HG is expressed in hippocampus proper.",
    "propertyCQ": "How is MIR3677HG expressed?",
    "objectCQ": "Where is MIR3677HG expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18052359$16B8479B-C63F-4FC2-AD09-1D467AD42806",
    "theme": "ChemicalCompound",
    "subject_label": "LINC02907",
    "subject_id": "Q18052359",
    "property_label": "expressed in",
    "property_id": "P5572",
    "object_label": "hippocampus proper",
    "object_id": "Q7308967",
    "context": "LINC02907 is expressed in the hippocampus proper.",
    "propertyCQ": "Where is LINC02907 located?",
    "objectCQ": "Where is LINC02907 expressed?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q34495787$6C397147-11FA-4084-BE1D-431620FE312E",
    "theme": "ChemicalCompound",
    "subject_label": "The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.",
    "subject_id": "Q34495787",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Oxytocin shapes the neural circuitry of trust and trust adaptation in humans.",
    "object_id": "Q34781060",
    "context": "The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans.",
    "propertyCQ": "What does MDMA do?",
    "objectCQ": "What does MDMA do to humans?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q36539089$5942E656-2AAA-4FBB-8300-BB44F51FF4D8",
    "theme": "ChemicalCompound",
    "subject_label": "Neuroimaging research in human MDMA users: a review.",
    "subject_id": "Q36539089",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB",
    "object_id": "Q24678394",
    "context": "Neuroimaging research in human MDMA users: a review. cites work on Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.",
    "propertyCQ": "What does the review do?",
    "objectCQ": "What is the focus of the review?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q35745285$068B516B-188D-40AE-94C3-97CD8466AB67",
    "theme": "ChemicalCompound",
    "subject_label": "Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.",
    "subject_id": "Q35745285",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine",
    "object_id": "Q24680216",
    "context": "MDMA, p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine have been shown to have an effect on the long-term and acute effects of MDMA on cerebral dopamine biochemistry and function.",
    "propertyCQ": "What is the purpose of this article?",
    "objectCQ": "What has been shown to have an effect on the long-term and acute effects of MDMA?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q38048826$868A3D35-86C9-453A-BCFD-E75D4AFCC88B",
    "theme": "ChemicalCompound",
    "subject_label": "Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.",
    "subject_id": "Q38048826",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Patterns of ecstasy-associated hyponatremia in California.",
    "object_id": "Q36644862",
    "context": "Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions. It cites work on Patterns of ecstasy-associated hyponatremia in California.",
    "propertyCQ": "What does the paper do?",
    "objectCQ": "What is the name of the work that is cited?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q30393293$67C26426-54FA-4CF2-89EA-EEE072EEB85E",
    "theme": "ChemicalCompound",
    "subject_label": "Self-Reported Ecstasy/MDMA/\"Molly\" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.",
    "subject_id": "Q30393293",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "The rise of new psychoactive substance use in Australia",
    "object_id": "Q57841993",
    "context": "Self-Reported Ecstasy/MDMA/\"Molly\" Use in a Sample of Nightclub and Dance Festival Attendees in New York City. and cites work on The rise of new psychoactive substance use in Australia.",
    "propertyCQ": "What does the article do?",
    "objectCQ": "What is the subject of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q43076563$2145E321-C4C3-45FA-9107-46CC0FF67C8D",
    "theme": "ChemicalCompound",
    "subject_label": "Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').",
    "subject_id": "Q43076563",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.",
    "object_id": "Q44671820",
    "context": "Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy'). It cites work entitled Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D(1) and D(2) receptors.",
    "propertyCQ": "What does caffeine do to promote ecstasy?",
    "objectCQ": "What is the name of the work that cites?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q51975344$F704AA57-7500-44A8-A753-8695FE5BE820",
    "theme": "ChemicalCompound",
    "subject_label": "Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.",
    "subject_id": "Q51975344",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Cannabis, ecstasy/MDMA and memory: a commentary on Simon & Mattick's recent study.",
    "object_id": "Q44482897",
    "context": "Cannabis, ecstasy/MDMA and memory: a commentary on Simon & Mattick's recent study. Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls.",
    "propertyCQ": "What does the article do?",
    "objectCQ": "What is the topic of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q37416406$0F2CF0B4-1DE2-46F7-BD48-6DFBBAEBF6B0",
    "theme": "ChemicalCompound",
    "subject_label": "Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.",
    "subject_id": "Q37416406",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.",
    "object_id": "Q34316202",
    "context": "Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice. It cites work on Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors.",
    "propertyCQ": "What does the study do?",
    "objectCQ": "What is the main effect of MDMA on the body?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q48865378$830F00E6-BA75-4408-B454-F35F0A761823",
    "theme": "ChemicalCompound",
    "subject_label": "Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA.",
    "subject_id": "Q48865378",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures.",
    "object_id": "Q42112531",
    "context": "Dopamine D1 receptor-mediated intracellular responses in the hypothalamus after co-administration of caffeine with MDMA. It cites work on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures.",
    "propertyCQ": "What does the study do?",
    "objectCQ": "What does the study cite?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q46808071$F0C42CFE-0B6D-44E0-9624-BE58571AC107",
    "theme": "ChemicalCompound",
    "subject_label": "Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.",
    "subject_id": "Q46808071",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Effects of beta-adrenoceptor blockade on components of human decision-making.",
    "object_id": "Q44723650",
    "context": "The study \"Effects of beta-adrenoceptor blockade on components of human decision-making\" cites the study \"Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.",
    "propertyCQ": "",
    "objectCQ": "What is the title of the study?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q34235666$51950B31-A379-4B5E-8CD2-E1CC19B3D393",
    "theme": "ChemicalCompound",
    "subject_label": "Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA).",
    "subject_id": "Q34235666",
    "property_label": "cites work",
    "property_id": "P2860",
    "object_label": "Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.",
    "object_id": "Q34734179",
    "context": "Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain. This study was published in the journal Nature.",
    "propertyCQ": "What does the journal Nature do with the results of the study?",
    "objectCQ": "What is the effect of beta-phenylethylamine on the brain?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593297$B61F3D01-0182-4807-8A20-F77BA9188797",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-320d",
    "subject_id": "Q27593297",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "hsa-mir-320d-1",
    "object_id": "Q27591126",
    "context": "Hsa-miR-320d is part of hsa-mir-320d-1.",
    "propertyCQ": "What is hsa-mir-320d-1?",
    "objectCQ": "What is the hsa-miR-320d part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50271844$19692596-E945-4142-AAFF-CE8A89C198D5",
    "theme": "ChemicalCompound",
    "subject_label": "NRG1/2:ERBB3 [plasma membrane]",
    "subject_id": "Q50271844",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "ERBB3 binds neuregulins",
    "object_id": "Q50297985",
    "context": "NRG1/2:ERBB3 [plasma membrane] is part of ERBB3 which binds neuregulins.",
    "propertyCQ": "What is ERBB3?",
    "objectCQ": "What does ERBB3 do?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50255921$1C16BC54-4405-48F8-A37B-C403EB3EDCF4",
    "theme": "ChemicalCompound",
    "subject_label": "Activated FGFR1:p-FRS2:p-PTPN11 [plasma membrane]",
    "subject_id": "Q50255921",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "Activated FGFR:p-FRS2:p-PTPN11:GRB2:GAB1:PIK3R1 [plasma membrane]",
    "object_id": "Q50255920",
    "context": "Activated FGFR1:p-FRS2:p-PTPN11 is part of FGFR1:p-FRS2:p-PTPN11:GRB2:GAB1:PIK3R1 [plasma membrane].",
    "propertyCQ": "What is FGFR1:p-FRS2:p-PTPN11?",
    "objectCQ": "What is part of FGFR1:p-FRS2:p-PTPN11?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50267551$6EF284C7-DBB5-4777-8670-07790AE0DF7E",
    "theme": "ChemicalCompound",
    "subject_label": "Exosome:SKI complex [cytosol]",
    "subject_id": "Q50267551",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "Exosome Complex hydrolyzes mRNA by 3' to 5' exoribonuclease digestion",
    "object_id": "Q50295866",
    "context": "Exosome:SKI complex (cytosol) is part of Exosome Complex which hydrolyzes mRNA by 3' to 5' exoribonuclease digestion.",
    "propertyCQ": "What is the SKI complex?",
    "objectCQ": "What is the name of the enzyme that is involved in the synthesis of mRNA?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q100147574$7EB79947-48A6-417B-862F-47EF7883E769",
    "theme": "ChemicalCompound",
    "subject_label": "sCD163:MYH9 [cytosol]",
    "subject_id": "Q100147574",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "sCD163 binds MYH9 in T-cells",
    "object_id": "Q100153192",
    "context": "SCD163:MYH9 [cytosol] is part of sCD163 and it binds MYH9 in T-cells.",
    "propertyCQ": "What part of sCD163 is MYH9?",
    "objectCQ": "What does sCD163 do?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50256790$8987ABFE-B6B8-48BC-9D84-FEC8E3838E9C",
    "theme": "ChemicalCompound",
    "subject_label": "Glycosylated, palmitylated and folded HA trimer [plasma membrane]",
    "subject_id": "Q50256790",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "Intracellular assembly complex [plasma membrane]",
    "object_id": "Q50256805",
    "context": "Glycosylated, palmitylated and folded HA trimer [plasma membrane] is part of the Intracellular assembly complex [plasma membrane].",
    "propertyCQ": "What is the HA trimer?",
    "objectCQ": "What is the HA trimer part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50264757$CACFD672-547C-4CAA-B57F-F03F8A397AC1",
    "theme": "ChemicalCompound",
    "subject_label": "HSD17B4 dimer [peroxisomal matrix]",
    "subject_id": "Q50264757",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA is hydrated to (24R, 25R) 3alpha,7alpha,24-trihydroxy-5beta-cholestanoyl-CoA",
    "object_id": "Q50294192",
    "context": "HSD17B4 dimer [peroxisomal matrix] is part of 25(S) 3alpha,7alpha-dihydroxy-5beta-cholest-24-enoyl-CoA and is hydrated to (24R, 25R) 3alpha,7alpha,24-trihydroxy-5beta-cholestanoyl-CoA.",
    "propertyCQ": "What is HSD17B4 dimer?",
    "objectCQ": "What is the HSD17B4 dimer part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593854$F620F10C-1662-45EB-9FB9-DA352815390F",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1250-3p",
    "subject_id": "Q27593854",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "hsa-mir-1250",
    "object_id": "Q27591524",
    "context": "Hsa-miR-1250-3p is part of hsa-mir-1250.",
    "propertyCQ": "What is hsa-mir-1250?",
    "objectCQ": "What is the Hsa-miR-1250-3p part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594455$94372CD8-3713-40D1-9974-3C2F82A34B61",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-563",
    "subject_id": "Q27594455",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "hsa-mir-563",
    "object_id": "Q27592026",
    "context": "Hsa-miR-563 is part of hsa-mir-563.",
    "propertyCQ": "What is hsa-mir-563?",
    "objectCQ": "What is the name of the hsa-miR-563?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50274802$74BD2F7A-7DA7-4D59-AF81-7B42D7C358FC",
    "theme": "ChemicalCompound",
    "subject_label": "spherical HDL:SR-BI complex [plasma membrane]",
    "subject_id": "Q50274802",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "Disassembly of SR-BI-bound spherical HDL",
    "object_id": "Q50299805",
    "context": "The spherical HDL:SR-BI complex (plasma membrane) is part of the disassembly of SR-BI-bound spherical HDL.",
    "propertyCQ": "What is the spherical HDL:SR-BI complex?",
    "objectCQ": "What is the SR-BI complex part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50256866$59A5241A-D4ED-4C4A-96B9-9E6AA7BDC795",
    "theme": "ChemicalCompound",
    "subject_label": "botA HC:LC dimer:SV2:GT1b [plasma membrane]",
    "subject_id": "Q50256866",
    "property_label": "part of",
    "property_id": "P361",
    "object_label": "botA HC:LC binds SV2A, B, or C and GT1b on the target cell surface",
    "object_id": "Q50289572",
    "context": "BotA HC:LC dimer:SV2:GT1b (plasma membrane) is part of botA HC:LC and binds SV2A, B, or C and GT1b on the target cell surface.",
    "propertyCQ": "What part of botA HC:LC is SV2:GT1b?",
    "objectCQ": "What does botA HC:LC do?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q29714083$FCB16B80-FE28-4623-B595-C3CD9FC4076C",
    "theme": "ChemicalCompound",
    "subject_label": "lncRNA:CR44921",
    "subject_id": "Q29714083",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "83D2-83D2|3-47.5 cM",
    "object_id": "",
    "context": "LncRNA:CR44921 has a cytogenetic location of 83D2-83D2|3-47.5 cM.",
    "propertyCQ": "What is the location of LncRNA:CR44921?",
    "objectCQ": "What is the cytogenetic location of LncRNA:CR44921?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18068645$F098014C-DC47-4CE6-A867-1210F84AEC79",
    "theme": "ChemicalCompound",
    "subject_label": "MIR1587",
    "subject_id": "Q18068645",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "Xp11.4",
    "object_id": "",
    "context": "Xp11.4 is the cytogenetic location of MIR1587.",
    "propertyCQ": "What is Xp11.4?",
    "objectCQ": "What is the cytogenetic location of MIR1587?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q24367309$167C30C5-0608-4824-B76D-D88BAA94028D",
    "theme": "ChemicalCompound",
    "subject_label": "LOC102547442",
    "subject_id": "Q24367309",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "16p12",
    "object_id": "",
    "context": "The cytogenetic location of LOC102547442 is 16p12.",
    "propertyCQ": "What is the location of LOC102547442?",
    "objectCQ": "What is the cytogenetic location of LOC102547442?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q24398790$CF3DF61C-DA4A-4D8D-ABF3-FCDB0E532669",
    "theme": "ChemicalCompound",
    "subject_label": "LOC103694052",
    "subject_id": "Q24398790",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "17p14",
    "object_id": "",
    "context": "The cytogenetic location of LOC103694052 is 17p14.",
    "propertyCQ": "What is the location of LOC103694052?",
    "objectCQ": "What is the cytogenetic location of LOC103694052?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18271220$9443CB10-8B2D-45F9-B51C-00C58EAAC4FE",
    "theme": "ChemicalCompound",
    "subject_label": "BB031773",
    "subject_id": "Q18271220",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "4|4 C6",
    "object_id": "",
    "context": "BB031773 has a cytogenetic location of 4|4 C6.",
    "propertyCQ": "What is the location of BB031773?",
    "objectCQ": "What is the cytogenetic location of BB031773?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18064146$8CA63836-A1E6-4CEA-B6F8-6C8BEC61D443",
    "theme": "ChemicalCompound",
    "subject_label": "TRH-GTG1-4",
    "subject_id": "Q18064146",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "1q21.2",
    "object_id": "",
    "context": "The cytogenetic location of TRH-GTG1-4 is 1q21.2.",
    "propertyCQ": "What is the location of TRH-GTG1-4?",
    "objectCQ": "What is the cytogenetic location of TRH-GTG1-4?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q29939697$1A8761B3-2EA8-4EBD-BA86-659300948026",
    "theme": "ChemicalCompound",
    "subject_label": "LOC108349963",
    "subject_id": "Q29939697",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "2q16",
    "object_id": "",
    "context": "The cytogenetic location of LOC108349963 is 2q16.",
    "propertyCQ": "What is the location of LOC108349963?",
    "objectCQ": "What is the cytogenetic location of LOC108349963?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18065823$8E090737-5596-467C-ADCF-E6D5B61A6F4A",
    "theme": "ChemicalCompound",
    "subject_label": "MIR1913",
    "subject_id": "Q18065823",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "6q27",
    "object_id": "",
    "context": "The cytogenetic location of MIR1913 is 6q27.",
    "propertyCQ": "What is the location of MIR1913?",
    "objectCQ": "What is the cytogenetic location of MIR1913?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20868901$B91F4A49-2071-42A3-9257-E2A32C663704",
    "theme": "ChemicalCompound",
    "subject_label": "Gm36372",
    "subject_id": "Q20868901",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "12 A1.1|12",
    "object_id": "",
    "context": "The cytogenetic location of Gm36372 is 12 A1.1|12.",
    "propertyCQ": "What is Gm36372's location?",
    "objectCQ": "What is the cytogenetic location of Gm36372?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q29937138$54FE74CD-E3A9-4EDF-A2A7-285357AF32A1",
    "theme": "ChemicalCompound",
    "subject_label": "LOC108352112",
    "subject_id": "Q29937138",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "10q26",
    "object_id": "",
    "context": "The cytogenetic location of LOC108352112 is 10q26.",
    "propertyCQ": "What is the location of LOC108352112?",
    "objectCQ": "What is the cytogenetic location of LOC108352112?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20865699$4ADBD175-61E8-4AAA-AA53-ED15BB508488",
    "theme": "ChemicalCompound",
    "subject_label": "Gm39513",
    "subject_id": "Q20865699",
    "property_label": "cytogenetic location",
    "property_id": "P4196",
    "object_label": "X A5|X",
    "object_id": "",
    "context": "X A5|X is the cytogenetic location of Gm39513.",
    "propertyCQ": "What is X A5|X?",
    "objectCQ": "What is the cytogenetic location of Gm39513?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90554444$0E6334B1-EB7E-4B75-893D-2D15EBE83B0A",
    "theme": "ChemicalCompound",
    "subject_label": "1-Naphthalenesulfonic acid, 3,3′-[1,4-phenylenebis(2,1-ethenediyl-4,1-phenyleneazo)]bis[4-amino-, disodium salt",
    "subject_id": "Q90554444",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "1-Naphthalenesulfonic acid, 3,3′-[1,4-phenylenebis(2,1-ethenediyl-4,1-phenyleneazo)]bis[4-amino-, disodium salt is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "propertyCQ": "Where is 1-Naphthalenesulfonic acid found?",
    "objectCQ": "Where is 1-Naphthalenesulfonic acid found?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90520585$E689508B-65AD-4104-AC6F-0A5D829F546E",
    "theme": "ChemicalCompound",
    "subject_label": "Carbamic acid, N-[[5-butyl-4′-[(2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl][1,1′-biphenyl]-2-yl]sulfonyl]-, phenylmethyl ester",
    "subject_id": "Q90520585",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "Carbamic acid, N-[[5-butyl-4′-[(2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl][1,1′-biphenyl]-2-yl]sulfonyl]-, phenylmethyl ester is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "propertyCQ": "Where is CAS COVID-19 Anti-Viral Candidate Compounds?",
    "objectCQ": "Where is carbamic acid found?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90508651$B4FDC350-9C87-4A4F-A58B-999681ACE3A6",
    "theme": "ChemicalCompound",
    "subject_label": "1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(2-methylpropoxy)-, (12aR)-",
    "subject_id": "Q90508651",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11R)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(2-methylpropoxy)-, (12aR)-",
    "propertyCQ": "What is the name of the chemistry in which the benzene is found?",
    "objectCQ": "What is the name of the compound that is used to treat HIV?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90486076$A9CD6D51-CF16-4F94-A4A4-9EBFA5A2B367",
    "theme": "ChemicalCompound",
    "subject_label": "2,7,10,12-Tetraazatridecanoic acid, 9-[2-(1H-imidazol-1-yl)ethyl]-12-methyl-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)-",
    "subject_id": "Q90486076",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "2,7,10,12-Tetraazatridecanoic acid, 9-[2-(1H-imidazol-1-yl)ethyl]-12-methyl-13-[2-(1H-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3R,6R,9S)- is in the catalog of CAS CO",
    "propertyCQ": "Where is the CAS CO ad?",
    "objectCQ": "What is the catalog of CAS COVID-19?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90507340$B091BE0D-B521-4EFF-A6F2-B82BCA51DE98",
    "theme": "ChemicalCompound",
    "subject_label": "1H-Pyrazole-3-carboxamide, 5-(2-fluorophenyl)-4,5-dihydro-1-pentyl-N-(1-tricyclo[3.3.1.13,7]dec-1-ylethyl)-",
    "subject_id": "Q90507340",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "1H-Pyrazole-3-carboxamide, 5-(2-fluorophenyl)-4,5-dihydro-1-pentyl-N-(1-tricyclo[3.3.1.13,7]dec-1-ylethyl)- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "propertyCQ": "Where is 1H-Pyrazole-3-carboxamide found?",
    "objectCQ": "What is the name of the product in the catalog?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90545592$E8EDEBDF-8019-4A15-BDB3-2DBA3B83BA39",
    "theme": "ChemicalCompound",
    "subject_label": "6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2R,6R)-6-(hydroxymethyl)-1,4-oxaselen-2-yl]-",
    "subject_id": "Q90545592",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2R,6R)-6-(hydroxymethyl)-1,4-oxaselen-2-yl]- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90534641$EA92A0E9-8C7A-4C34-8DAE-BCE3C878C508",
    "theme": "ChemicalCompound",
    "subject_label": "Benzamide, N-[9-(2-O-methyl-β-D-arabinofuranosyl)-9H-purin-6-yl]-",
    "subject_id": "Q90534641",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "Benzamide, N-[9-(2-O-methyl-β-D-arabinofuranosyl)-9H-purin-6-yl]- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90519486$D98D6C19-238B-4AF5-B33C-1D6432923424",
    "theme": "ChemicalCompound",
    "subject_label": "D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-, 7-[[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]hexyl]carbamate]",
    "subject_id": "Q90519486",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-, 7-[[6-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-",
    "propertyCQ": "What is the name of the acid in the D-glycero-D-galacto-Non-2-enonic acid?",
    "objectCQ": "What is the name of the compound that is used to treat HIV?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90518042$6FA6AF55-7C71-4C5A-ADA1-62D65E7F28DA",
    "theme": "ChemicalCompound",
    "subject_label": "Carbamic acid, [2-hydroxy-3-[[(4-hydroxyphenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)propyl]-, tetrahydro-3-furanyl ester, [3S-[3R*(1R*,2R*)]]-",
    "subject_id": "Q90518042",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "Carbamic acid, [2-hydroxy-3-[((4-hydroxyphenyl)sulfonyl](2-methylpropyl)amino]-1-(phenylmethyl)propyl]-, tetrahydro-3-furanyl ester, [3S-[3R*(1R*,2R*)]- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "propertyCQ": "Where is carbamic acid found?",
    "objectCQ": "Where is carbamic acid found?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90522923$786663C8-ACAD-447C-B76E-A2FB0F5B4007",
    "theme": "ChemicalCompound",
    "subject_label": "1099829-95-4",
    "subject_id": "Q90522923",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "1099829-95-4 is a catalog for CAS COVID-19 Anti-Viral Candidate Compounds.",
    "propertyCQ": "What is 1099829-95-4?",
    "objectCQ": "What is the 1099829-95-4 catalog for?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90532690$966D9EB2-4616-4993-9B5C-382340CCD7CF",
    "theme": "ChemicalCompound",
    "subject_label": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-[1-[2-[4-(4-morpholinyl)-6-[(phenylmethyl)amino]-1,3,5-triazin-2-yl]hydrazinyl]ethylidene]-",
    "subject_id": "Q90532690",
    "property_label": "catalog",
    "property_id": "P972",
    "object_label": "CAS COVID-19 Anti-Viral Candidate Compounds",
    "object_id": "Q90481889",
    "context": "2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-[1-[2-[4-(4-morpholinyl)-6-[(phenylmethyl)amino]-1,3,5-triazin-2-yl]hydrazinyl]ethylidene]- is in the catalog of CAS COVID-19 Anti-Viral Candidate Compounds.",
    "propertyCQ": "",
    "objectCQ": "What is the name of the compound that contains Pyrimidinetrione?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q106512863$A297FEAA-B765-476C-B11E-FC557C93513D",
    "theme": "ChemicalCompound",
    "subject_label": "KCNMA1:KCNMB1:LRRC52 [plasma membrane]",
    "subject_id": "Q106512863",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "KCNMA1:KCNMB1 [plasma membrane]",
    "object_id": "Q106512862",
    "context": "KCNMA1:KCNMB1:LRRC52 [plasma membrane] has part of it.",
    "propertyCQ": "What part of the membrane does KCNMB1:LRRC52 have?",
    "objectCQ": "What is part of the KCNMA1?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50255573$F32047B2-5864-45EC-A3F3-74234949B243",
    "theme": "ChemicalCompound",
    "subject_label": "p-FGFR1 mutant fusions:PI3K [cytosol]",
    "subject_id": "Q50255573",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "p-FGFR1 fusion mutant dimers:PIK3R1 [cytosol]",
    "object_id": "Q50255571",
    "context": "P-FGFR1 mutant fusions:PI3K [cytosol] have part of p-FGFR1 fusion mutant dimers:PIK3R1 [cytosol].",
    "propertyCQ": "What part of p-FGFR1 fusion mutant dimers does PI3K have?",
    "objectCQ": "What do P-FGFR1 mutant fusions:PI3K [cytosol] have part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50255203$9C3FBD72-A5D0-43BF-BE41-71D78F471F70",
    "theme": "ChemicalCompound",
    "subject_label": "HOXB1:PBX1:PKNOX1 and MEIS1 at active HOXB1 chromatin [nucleoplasm]",
    "subject_id": "Q50255203",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "HOXB1:PBX1:PKNOX1 [nucleoplasm]",
    "object_id": "Q50255206",
    "context": "HOXB1:PBX1:PKNOX1 and MEIS1 at active HOXB1 chromatin [nucleoplasm] has part of HOXB1:PBX1:PKNOX1 [nucleoplasm].",
    "propertyCQ": "What part of HOXB1:PBX1:PKNOX1 does?",
    "objectCQ": "What part of HOXB1 chromatin is a part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q100148865$3C8BDD1B-DB62-4E8C-9471-1325265A0210",
    "theme": "ChemicalCompound",
    "subject_label": "GRIN1:GRIN2A di-heterotetramer [endoplasmic reticulum membrane]",
    "subject_id": "Q100148865",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "Glutamate ionotropic receptor NMDA type subunit 1",
    "object_id": "Q21118862",
    "context": "GRIN1:GRIN2A di-heterotetramer [endoplasmic reticulum membrane] has part of Glutamate ionotropic receptor NMDA type subunit 1.",
    "propertyCQ": "What part of GRIN2A is present in the Glutamate ionotropic receptor NMDA type subunit 1?",
    "objectCQ": "What does GRIN2A have a part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50266425$BFB86720-7F22-4A8B-98B5-5E85560B1BA3",
    "theme": "ChemicalCompound",
    "subject_label": "PXLP-K258-NFS1-2 dimer [cytosol]",
    "subject_id": "Q50266425",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "PXLP-K258-NFS1-2 [cytosol]",
    "object_id": "Q99979918",
    "context": "PXLP-K258-NFS1-2 dimer [cytosol] has part of it.",
    "propertyCQ": "What part of the cytosol does the PXLP-K258-NFS1-2 dimer have?",
    "objectCQ": "What part of the protein is part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q100147038$62683469-330C-40C6-AB82-9D8E443AD16D",
    "theme": "ChemicalCompound",
    "subject_label": "activated RAF1 mutant:scaffold:p-2S MAP2K:p-2T MAPK complex [plasma membrane]",
    "subject_id": "Q100147038",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "RAF/MAPK scaffolds [cytosol]",
    "object_id": "Q50256200",
    "context": "The activated RAF1 mutant:scaffold:p-2S MAP2K:p-2T MAPK complex [plasma membrane] has part of RAF/MAPK scaffolds [cytosol].",
    "propertyCQ": "",
    "objectCQ": "What does the RAF1 mutant have a part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50256467$F4CB01B2-2554-4C86-8260-C0914D6105D3",
    "theme": "ChemicalCompound",
    "subject_label": "CCR5/CXCR4:CD4:Env gp120 (second conformation change) complex [plasma membrane]",
    "subject_id": "Q50256467",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "CCR5, CXCR4 [plasma membrane]",
    "object_id": "Q50256463",
    "context": "CCR5/CXCR4:CD4:Env gp120 (second conformation change) complex [plasma membrane] has part of CCR5/CXCR4 [plasma membrane].",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q106512844$0BA69B3F-2385-47AE-AC4A-3399FBF23B27",
    "theme": "ChemicalCompound",
    "subject_label": "Stereocilium rootlet [cytosol]",
    "subject_id": "Q106512844",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "Spectrin beta, non-erythrocytic 1",
    "object_id": "Q21112182",
    "context": "Stereocilium rootlet [cytosol] has part of Spectrin beta, non-erythrocytic 1.",
    "propertyCQ": "What part of Spectrin beta does stereocilium rootlet have?",
    "objectCQ": "Stereocilium rootlet has part of what?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18211640$AD3740E8-B421-4B48-8F4A-89A2D76520E6",
    "theme": "ChemicalCompound",
    "subject_label": "Гипофосфит лития",
    "subject_id": "Q18211640",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "phosphorus",
    "object_id": "Q674",
    "context": "Гипофосфит лития has part of phosphorus.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50254399$2383DAC1-22CE-4451-A454-543C8D8ADDBA",
    "theme": "ChemicalCompound",
    "subject_label": "ROBO2:SLIT2 [plasma membrane]",
    "subject_id": "Q50254399",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "Roundabout guidance receptor 2",
    "object_id": "Q21134297",
    "context": "ROBO2:SLIT2 [plasma membrane] has part of Roundabout guidance receptor 2.",
    "propertyCQ": "What part of Roundabout guidance receptor 2 does ROBO2:SLIT2 have?",
    "objectCQ": "What does ROBO2:SLIT2 have a part of?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q20986187$D5B63B9F-DAAF-438A-808B-CEA4EA15E357",
    "theme": "ChemicalCompound",
    "subject_label": "Сульфит родия(III)",
    "subject_id": "Q20986187",
    "property_label": "has part",
    "property_id": "P527",
    "object_label": "oxygen",
    "object_id": "Q629",
    "context": "Сульфит родия(III) has part of oxygen.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27140577$32CADF2A-4041-4A03-81EF-AC57EBCC06FC",
    "theme": "ChemicalCompound",
    "subject_label": "Glu-Ile-Val",
    "subject_id": "Q27140577",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "359.206 dalton",
    "object_id": "",
    "context": "Glu-Ile-Val has a mass of 359.206 dalton.",
    "propertyCQ": "What is the mass of Glu-Ile-Val?",
    "objectCQ": "What is the mass of Glu-Ile-Val?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q1720750$AAA4751B-E101-49B4-9023-FD87483C7911",
    "theme": "ChemicalCompound",
    "subject_label": "tiflorex",
    "subject_id": "Q1720750",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "263.096 dalton",
    "object_id": "",
    "context": "Tiflorex has a mass of 263.096 dalton.",
    "propertyCQ": "What is Tiflorex's metric?",
    "objectCQ": "What is Tiflorex's mass?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27106464$20585F7A-4C77-46A4-BEC2-D36A2C2315D9",
    "theme": "ChemicalCompound",
    "subject_label": "echinocystic acid",
    "subject_id": "Q27106464",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "472.355 dalton",
    "object_id": "",
    "context": "Echinocystic acid has a mass of 472.355 dalton.",
    "propertyCQ": "What is the echinocystic acid's what?",
    "objectCQ": "What is the mass of echinocystic acid?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27286410$D5FD5678-230B-447B-A7A5-F306093831E3",
    "theme": "ChemicalCompound",
    "subject_label": "2-amino-N-isopropylbenzamide",
    "subject_id": "Q27286410",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "178.111 dalton",
    "object_id": "",
    "context": "2-amino-N-isopropylbenzamide has a mass of 178.111 dalton.",
    "propertyCQ": "What is the 178.111 dalton of 2-amino-N-isopropylbenzamide?",
    "objectCQ": "What is the mass of 2-amino-N-isopropylbenzamide?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27271459$39E682C4-690E-41B7-81C8-1602A5D62ACF",
    "theme": "ChemicalCompound",
    "subject_label": "isotretinoin anisatil",
    "subject_id": "Q27271459",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "448.261 dalton",
    "object_id": "",
    "context": "The isotretinoin anisatil has a mass of 448.261 dalton.",
    "propertyCQ": "What is the amount of isotretinoin anisatil?",
    "objectCQ": "What is the mass of isotretinoin anisatil?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27222677$6B264AE4-9FB7-4F29-8AF8-90DF5D54B68D",
    "theme": "ChemicalCompound",
    "subject_label": "[(3aR,4R,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-(1,3-benzodioxol-5-yl)methanone",
    "subject_id": "Q27222677",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "472.2 dalton",
    "object_id": "",
    "context": "[(3aR,4R,9bS)-4-(hydroxymethyl)-8-(3-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-(1,3-benzodioxol-5-yl)methanone has a mass of 472.2 dalton.",
    "propertyCQ": "What is the mass of methanone?",
    "objectCQ": "What is the mass of methanone?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27113884$EBBB9E36-7454-4F31-8CEF-1874ED07CFEB",
    "theme": "ChemicalCompound",
    "subject_label": "disilicon",
    "subject_id": "Q27113884",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "55.953853 dalton",
    "object_id": "",
    "context": "The disilicon has a mass of 55.953853 dalton.",
    "propertyCQ": "What is the disilicon's what?",
    "objectCQ": "What is the mass of the disilicon?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27452188$41D4014F-9863-4E6B-A0FA-924567A852FD",
    "theme": "ChemicalCompound",
    "subject_label": "6-({(1S,5R)-3-[2-(3,4-dimethoxyphenoxy)ethyl]-2-oxo-3,9-diazabicyclo[3.3.1]non-9-yl}sulfonyl)-1,3-benzothiazol-2(3H)-one",
    "subject_id": "Q27452188",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "533.129 dalton",
    "object_id": "",
    "context": "6-({(1S,5R)-3-[2-(3,4-dimethoxyphenoxy)ethyl]-2-oxo-3,9-diazabicyclo[3.3.1]non-9-yl}sulfonyl)-1,3-benzothiazol-2(3H)-one has a mass of 533.129 dalton.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27186775$F4395306-C7A7-462A-B65A-D4B193BACFB5",
    "theme": "ChemicalCompound",
    "subject_label": "1-(2-furanyl)-3-(phenylthio)-3-thiophen-2-yl-1-propanone",
    "subject_id": "Q27186775",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "314.044 dalton",
    "object_id": "",
    "context": "1-(2-furanyl)-3-(phenylthio)-3-thiophen-2-yl-1-propanone has a mass of 314.044 dalton.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27177221$E8922BD7-52A1-4721-9FD8-17EE9EDB95DD",
    "theme": "ChemicalCompound",
    "subject_label": "4-[3-[(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]benzonitrile",
    "subject_id": "Q27177221",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "571.261711 dalton",
    "object_id": "",
    "context": "4-[3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[(4-methyl-1-piperazinyl)-oxomethyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]benzonitrile has a mass of 571.261711 dalton.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27253555$A6C4AA7E-C4AD-4F31-9AAF-DF63CDFDBE5F",
    "theme": "ChemicalCompound",
    "subject_label": "(R)-am-1241",
    "subject_id": "Q27253555",
    "property_label": "mass",
    "property_id": "P2067",
    "object_label": "503.071 dalton",
    "object_id": "",
    "context": "(R)-am-1241 has a mass of 503.071 dalton.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27592931$CA9039BC-42E2-426C-AFB7-0D088608AF29",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1537-5p",
    "subject_id": "Q27592931",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "SLC9A8",
    "object_id": "Q18037085",
    "context": "Hsa-miR-1537-5p regulates (molecular biology) and SLC9A8.",
    "propertyCQ": "What does Hsa-miR-1537-5p do?",
    "objectCQ": "What does Hsa-miR-1537-5p regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593348$4585F165-D775-4167-9ED2-2C750BD9F97B",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-548ar-3p",
    "subject_id": "Q27593348",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "PITPNB",
    "object_id": "Q18037630",
    "context": "Hsa-miR-548ar-3p regulates (molecular biology) and PITPNB.",
    "propertyCQ": "What does Hsa-miR-548ar-3p do?",
    "objectCQ": "What does Hsa-miR-548ar-3p regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594944$A625935F-5CCA-4757-8448-347C01791A62",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-4468",
    "subject_id": "Q27594944",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "NPM1",
    "object_id": "Q18030194",
    "context": "Hsa-miR-4468 regulates (molecular biology) NPM1.",
    "propertyCQ": "What does Hsa-miR-4468 do?",
    "objectCQ": "What does Hsa-miR-4468 regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594461$0FA9FC31-0D10-4DF8-93E9-AF8AE6A67A64",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-466",
    "subject_id": "Q27594461",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "FGF2",
    "object_id": "Q20969945",
    "context": "Hsa-miR-466 regulates (molecular biology) FGF2.",
    "propertyCQ": "What does Hsa-miR-466 do?",
    "objectCQ": "What does Hsa-miR-466 regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594974$AAB9D602-DF00-40B2-B09D-8D92C08DD26D",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-320a",
    "subject_id": "Q27594974",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "TOE1",
    "object_id": "Q18048937",
    "context": "Hsa-miR-320a regulates (molecular biology) TOE1.",
    "propertyCQ": "What does Hsa-miR-320a do?",
    "objectCQ": "What does Hsa-miR-320a regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593002$1519258D-FA7A-4217-A03E-6F56471C5B00",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-1307-3p",
    "subject_id": "Q27593002",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "IL6R",
    "object_id": "Q18027836",
    "context": "Hsa-miR-1307-3p regulates (molecular biology) IL6R.",
    "propertyCQ": "What does Hsa-miR-1307-3p do?",
    "objectCQ": "What does Hsa-miR-1307-3p regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593406$6D783EA4-974D-4E3B-8E8C-D83C569C1632",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-431-5p",
    "subject_id": "Q27593406",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "BRMS1L",
    "object_id": "Q18047558",
    "context": "Hsa-miR-431-5p regulates (molecular biology) BRMS1L.",
    "propertyCQ": "What does Hsa-miR-431-5p do?",
    "objectCQ": "What does Hsa-miR-431-5p regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27593357$5C6FECC2-6AEF-4CBF-9CD5-0BA78A5FA790",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-7703",
    "subject_id": "Q27593357",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "OTUD7B",
    "object_id": "Q18042708",
    "context": "Hsa-miR-7703 regulates (molecular biology) OTUD7B.",
    "propertyCQ": "What does Hsa-miR-7703 do?",
    "objectCQ": "What does Hsa-miR-7703 regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27595321$E5FC448D-F484-435F-AD7F-A5D74628DF27",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-507",
    "subject_id": "Q27595321",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "DNAJC15",
    "object_id": "Q18039606",
    "context": "Hsa-miR-507 regulates (molecular biology) and DNAJC15.",
    "propertyCQ": "What does Hsa-miR-507 do?",
    "objectCQ": "What does Hsa-miR-507 regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594953$2CF208A8-ECA2-484B-A4D4-24360EC0AE93",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-3674",
    "subject_id": "Q27594953",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "PLAG1",
    "object_id": "Q18030577",
    "context": "Hsa-miR-3674 regulates (molecular biology) PLAG1.",
    "propertyCQ": "What does Hsa-miR-3674 do?",
    "objectCQ": "What does Hsa-miR-3674 regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27594184$075E5017-4EE8-48DD-B2BB-F60A55C55029",
    "theme": "ChemicalCompound",
    "subject_label": "hsa-miR-4436a",
    "subject_id": "Q27594184",
    "property_label": "regulates (molecular biology)",
    "property_id": "P128",
    "object_label": "CMTM4",
    "object_id": "Q18051441",
    "context": "Hsa-miR-4436a regulates (molecular biology) and CMTM4.",
    "propertyCQ": "What does Hsa-miR-4436a do?",
    "objectCQ": "What does Hsa-miR-4436a regulate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q76545451$4B78C15D-DFD7-4E43-A64F-9051565D5CC6",
    "theme": "ChemicalCompound",
    "subject_label": "5-[[(2S)-2-cyclopropyl-7,8-dimethoxy-3,4-dihydro-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",
    "subject_id": "Q76545451",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "COC1=C(C2=C(CC[C@H](O2)C3CC3)C(=C1)CC4=CN=C(N=C4N)N)OC",
    "object_id": "",
    "context": "5-[(2S)-2-cyclopropyl-7,8-dimethoxy-3,4-dihydro-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine has isomeric SMILES. COC1=C(C2=C(CC[C@H](O2)C3CC3)C(=C1)CC4=CN=C(N=C4N)N)OC.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27280671$30FEA8EE-0E37-45A3-9AC2-F1C402248204",
    "theme": "ChemicalCompound",
    "subject_label": "travoprost 5,6-trans isomer",
    "subject_id": "Q27280671",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)O)O",
    "object_id": "",
    "context": "Travoprost 5,6-trans isomer has isomeric SMILES. CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H]([C@H]1/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)O)O)O.",
    "propertyCQ": "",
    "objectCQ": "What is the SMILE of Travoprost?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104888894$50F3A4AE-577A-427D-BA11-8958BB7E037E",
    "theme": "ChemicalCompound",
    "subject_label": "(2S)-N-[(3S,4R,7R,10Z)-5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid",
    "subject_id": "Q104888894",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "CC(C)C[C@@H](C(O)=N[C@H]1C(O)=N[C@H](CC(C)C)C(O)=N/C=C\\c2ccc(cc2)O[C@H]1C(C)C)N(C)C",
    "object_id": "",
    "context": "(2S)-N-[(3S,4R,7R,10Z)-5,8-dihydroxy-3-isopropyl-7-(2-methylpropyl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl]-2-(dimethylamino)-4-methylpentanimidic acid is isomeric SMI",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q105181292$0DE91F0E-2099-47F3-8D65-323F3DABEE70",
    "theme": "ChemicalCompound",
    "subject_label": "(1R,3R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (1R,2S,3S,4S,5R)-3,4-dihydroxy-6,6-dimethylbicyclo[3.1.1]heptane-2-carboxylate",
    "subject_id": "Q105181292",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)[C@@H]1[C@H](O)[C@@H](O)[C@@H]3C[C@H]1C3(C)C)C2",
    "object_id": "",
    "context": "CN1[C@H]2CC[C@H](OC(=O)[C@@H](O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H](C(O)[C@@H]",
    "propertyCQ": "What type of SMILES are there?",
    "objectCQ": "What is the name of the organization that is responsible for the operation of the computer?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104970386$7F799A85-5611-43A8-AEED-707C10DBD378",
    "theme": "ChemicalCompound",
    "subject_label": "5-hydroxy-2-(3-hydroxy-4-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-4-one",
    "subject_id": "Q104970386",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C[C@@H]1O[C@@H](Oc2cc(O)c3c(=O)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(-c4ccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(O)c4)oc3c2)[C@H](O)[C@H](O)[C@H]1O",
    "object_id": "",
    "context": "C[C@@H](Oc2cc(O)c3c(O(C@@H)(CO)[C@@H](C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H](O)[C@H]",
    "propertyCQ": "What type of SMILES are there?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q76620930$9B14DBE9-9F98-4874-A60D-6513D8C75C8F",
    "theme": "ChemicalCompound",
    "subject_label": "(2R,3R,5S,6R)-3-amino-6-methyloxane-2,5-diol",
    "subject_id": "Q76620930",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C[C@@H]1[C@H](C[C@H]([C@@H](O1)O)N)O",
    "object_id": "",
    "context": "2R,3R,5S,6R)-3-amino-6-methyloxane-2,5-diol are isomeric SMILES. C[C@@H]1[C@H]([C@@H](O1)O)N)O.",
    "propertyCQ": "",
    "objectCQ": "What is the name of the isomeric SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104952380$3C928978-C8C3-48BC-9264-8C3FEBDA4A40",
    "theme": "ChemicalCompound",
    "subject_label": "(1S,4S,5R,8R,9R,13R,14R,17S,18R,19S,20R)-9-(hydroxymethyl)-4,5,9,13,19,20-hexamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracosane-10,16-dione",
    "subject_id": "Q104952380",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C[C@H]1[C@H](C)CC[C@@]23CC[C@]4(C)[C@](OC2)(C(=O)C[C@@H]2[C@@]5(C)CCC(=O)[C@@](C)(CO)[C@@H]5CC[C@]24C)[C@H]13",
    "object_id": "",
    "context": "(1S,4S,5R,8R,9R,13R,14R,17S,18R,19S,20R)-9-(hydroxymethyl)-4,5,9,13,19,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracosane-10,16-dione isomeric SMILES.",
    "propertyCQ": "",
    "objectCQ": "What is the name of the molecule that is a tetracosane isomeric SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27088999$680FDE77-C947-4E87-A7EE-B24DEE6F0647",
    "theme": "ChemicalCompound",
    "subject_label": "tirotundin",
    "subject_id": "Q27088999",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C[C@H]1C[C@@H]2[C@@H]([C@@H](C[C@@]3(CC[C@]1(O3)O)C)OC(=O)C(C)C)C(=C)C(=O)O2",
    "object_id": "",
    "context": "The isomeric SMILES of tirotundin are C[C@H]1C[C@@H]2[C@@H]([C@@H]([CC[C@]1(O3)O)C)OC(=O)C(=C)C(=O)O2).",
    "propertyCQ": "What is the name of the isomeric SMILES of tirotundin?",
    "objectCQ": "What are the isomeric SMILES of tirotundin?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q105155579$50C1FDBC-4DE3-426A-824E-80FDC2007708",
    "theme": "ChemicalCompound",
    "subject_label": "LQJQZJOGDGMAIX-AIWCGGGXSA-N",
    "subject_id": "Q105155579",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "CCCCCCCCCCC[C@H](C)[C@@H]1CC(O)=N[C@H]([C@H](C)O)C(O)=N[C@H](C)C(O)=N[C@H](C)C(O)=N[C@H](CCC(=N)O)C(O)=N[C@H](Cc2ccc(C)cc2)C(O)=N[C@H]([C@@H](C)CC)C(=O)O1",
    "object_id": "",
    "context": "LQJQZJOGDGMAIX-AIWCGGGXSA-N contains isomeric SMILES. CCCCCCCCC[C@H]([C@H](C)O)C(O)=N[C@H](Cc2ccc(C)cc2)C(O)=N[C@H]([C@H](C(C)C(O)=N[C@H]([C@H](C",
    "propertyCQ": "What does the LQJQZJOGDGMAIX-AIWCGGGXSA-N contain?",
    "objectCQ": "What is the name of the isomeric SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q105153389$AC278880-16E6-47E4-BFF9-7C3C3091D42A",
    "theme": "ChemicalCompound",
    "subject_label": "(1'S,2R,2'S,4'S,7'S,8'R,9'S,12'S,13'S,14'R,16'S,17'S,18'R)-7',9',13'-trimethyl-5-methylidene-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-14',16',17',18'-tetrol",
    "subject_id": "Q105153389",
    "property_label": "isomeric SMILES",
    "property_id": "P2017",
    "object_label": "C=C1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@]5(O)[C@@H](O)[C@@H](O)C[C@@H](O)[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C",
    "object_id": "",
    "context": "C=C1CC[C@@]2(OC1)O[C@H]3[C@@H](C(C)[C@@H](C(C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](",
    "propertyCQ": "What type of SMILES are there?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104397467$859BE82A-5341-4D42-AE56-B6716C861076",
    "theme": "ChemicalCompound",
    "subject_label": "(1S,3E,5R,7R)-3-[hydroxy(phenyl)methylidene]-6,6-dimethyl-1,5,7-tris(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione",
    "subject_id": "Q104397467",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Clusia pernambucensis",
    "object_id": "Q15354473",
    "context": "(1S,3E,5R,7R)-3-[hydroxy(phenyl)methylidene]-6,6-dimethyl-1,5,7-tris(3-methylbut-2-en-1-yl)bicyclo[3.3.1]nonane-2,4,9-trione is found in the taxon Clusia pernambucensis.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q18302875$FF72837F-000D-4047-9047-3F34FDD2F371",
    "theme": "ChemicalCompound",
    "subject_label": "B430212C06Rik",
    "subject_id": "Q18302875",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "house mouse",
    "object_id": "Q83310",
    "context": "B430212C06Rik is found in the taxon house mouse.",
    "propertyCQ": "Where is B430212C06Rik found?",
    "objectCQ": "What taxon is B430212C06Rik found in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q103787031$1949A696-91A6-4C55-8215-7FB5D4F48FB9",
    "theme": "ChemicalCompound",
    "subject_label": "methyl (1R,9R,16R,18R,21S)-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-18-carboxylate",
    "subject_id": "Q103787031",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Kopsia arborea",
    "object_id": "Q15358450",
    "context": "Methyl (1R,9R,16R,18R,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7,14-tetraene-18-carboxylate is found in the taxon Kopsia arborea.",
    "propertyCQ": "Where is henicosa found?",
    "objectCQ": "Where is henicosa found?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q412366$B3BB3D89-4AA4-4EC4-9C42-79C36AAD0C15",
    "theme": "ChemicalCompound",
    "subject_label": "palmitoleic acid",
    "subject_id": "Q412366",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Oenothera villosa",
    "object_id": "Q15251034",
    "context": "Palmitoleic acid is found in the taxon Oenothera villosa.",
    "propertyCQ": "Where is palmitoleic acid found?",
    "objectCQ": "What taxon is palmitoleic acid found in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27120911$2DB88A3D-98D6-4F50-9C86-4551857E56C0",
    "theme": "ChemicalCompound",
    "subject_label": "4-methyleneglutamic acid",
    "subject_id": "Q27120911",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Lilium candidum",
    "object_id": "Q159811",
    "context": "4-methyleneglutamic acid is found in the taxon of Lilium candidum.",
    "propertyCQ": "Where is 4-methyleneglutamic acid found?",
    "objectCQ": "What plant has 4-methyleneglutamic acid?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q425004$F982BC90-FF4A-4B7C-B472-4549197EA6D9",
    "theme": "ChemicalCompound",
    "subject_label": "stigmasterol",
    "subject_id": "Q425004",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Symphyotrichum novi-belgii",
    "object_id": "Q1537333",
    "context": "Stigmasterol is found in the taxon Symphyotrichum novi-belgii.",
    "propertyCQ": "Where is stambuterol found?",
    "objectCQ": "Where is stambuterol found?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q7050291$58593F51-A5EE-4783-B05B-0526563D917D",
    "theme": "ChemicalCompound",
    "subject_label": "Norbergenin",
    "subject_id": "Q7050291",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Ardisia japonica",
    "object_id": "Q858326",
    "context": "Norbergenin is found in the taxon Ardisia japonica.",
    "propertyCQ": "Where is Norbergenin found?",
    "objectCQ": "Where is Norbergenin found?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q29698858$AEFEF2C8-D92D-405F-9BD1-FEC348B9CC11",
    "theme": "ChemicalCompound",
    "subject_label": "21ur-12267",
    "subject_id": "Q29698858",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Caenorhabditis elegans",
    "object_id": "Q91703",
    "context": "21ur-12267 is found in the taxon of Caenorhabditis elegans.",
    "propertyCQ": "Where is 21ur-12267 found?",
    "objectCQ": "What taxon is 21ur-12267 found in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q104917814$DD041FC4-9900-40F1-BADF-DD19E3562355",
    "theme": "ChemicalCompound",
    "subject_label": "2-(3,4-dihydroxy-5-methoxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one",
    "subject_id": "Q104917814",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Stachys scardica",
    "object_id": "Q15369004",
    "context": "2-(3,4-dihydroxy-5-methoxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one is found in the taxon Stachys scardica.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q50260183$DA1E3AE6-445A-4E92-9A9A-D6855D196F67",
    "theme": "ChemicalCompound",
    "subject_label": "Antigen peptide bound class I MHC [integral component of lumenal side of endoplasmic reticulum membrane]",
    "subject_id": "Q50260183",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Homo sapiens",
    "object_id": "Q15978631",
    "context": "Antigen peptide bound class I MHC (integral component of lumenal side of endoplasmic reticulum membrane) is found in the taxon Homo sapiens.",
    "propertyCQ": "Where is antigen peptide bound class I MHC found?",
    "objectCQ": "What taxon is antigen peptide bound class I MHC found in?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q2317288$93402D8C-8178-4B4D-A870-AFCF8E977568",
    "theme": "ChemicalCompound",
    "subject_label": "luteoloside",
    "subject_id": "Q2317288",
    "property_label": "found in taxon",
    "property_id": "P703",
    "object_label": "Hieracium coloriscapum",
    "object_id": "Q104850018",
    "context": "Luteoloside is found in the taxon of Hieracium coloriscapum.",
    "propertyCQ": "Where is Luteoloside found?",
    "objectCQ": "Luteoloside is found in the taxon of what plant?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82403657$A3E36D8A-BBBD-4D67-AB12-BD331FA86D56",
    "theme": "ChemicalCompound",
    "subject_label": "2-Bromo-5-[3-(bromomethyl)phenyl]furan",
    "subject_id": "Q82403657",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "C1=CC(=CC(=C1)C2=CC=C(O2)Br)CBr",
    "object_id": "",
    "context": "2-Bromo-5-[3-(bromomethyl)phenyl]furan is canonical SMILES. C1=CC(=CC(=C1)C2=CC=C(O2)Br)CBr.",
    "propertyCQ": "",
    "objectCQ": "What is the C1 of the SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82807922$49E10339-2CBD-41AD-BC13-E602D2DBB96B",
    "theme": "ChemicalCompound",
    "subject_label": "2,4-Dichloro-5-[(methylsulfanyl)methyl]pyrimidine",
    "subject_id": "Q82807922",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CSCC1=CN=C(N=C1Cl)Cl",
    "object_id": "",
    "context": "2,4-Dichloro-5-[(methylsulfanyl)methyl]pyrimidine is canonical SMILES. CSCC1=CN=C(N=C1Cl)Cl.",
    "propertyCQ": "",
    "objectCQ": "What is the CSCC1?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83035680$8F3546EF-3390-4E57-B6AA-67953A5B8476",
    "theme": "ChemicalCompound",
    "subject_label": "Methane, dichlorodinitro-",
    "subject_id": "Q83035680",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "C([N+](=O)[O-])([N+](=O)[O-])(Cl)Cl",
    "object_id": "",
    "context": "Methane, dichlorodinitro- is canonical SMILES. C([N+](=O)[O-])(Cl)Cl.",
    "propertyCQ": "What is methane?",
    "objectCQ": "What is the chemical name of the molecule that is a SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27160123$41E82FF4-08ED-4F29-BF10-4EB62917871A",
    "theme": "ChemicalCompound",
    "subject_label": "Congo corinth (acid form)",
    "subject_id": "Q27160123",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "C1=CC=C2C(=C1)C(=CC(=C2N)N=NC3=CC=C(C=C3)C4=CC=C(C=C4)N=NC=5C=C(C6=CC=CC=C6C5O)S(O)(=O)=O)S(O)(=O)=O",
    "object_id": "",
    "context": "C1=CC=C2C(=C1)C(=CC(=C2N)N=NC3=CC(C3)C4=CC(C4)N=NC=5C=C(C6=CC=C6C5O)S(O)(=O)(=O)=O.",
    "propertyCQ": "What is the name of the SMILES?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q81997661$BDA4E37F-6476-464F-B41A-76F01A0AC2D5",
    "theme": "ChemicalCompound",
    "subject_label": "Benzoic acid, 2-amino-5-[(4-aminophenyl)methyl]-, butyl ester",
    "subject_id": "Q81997661",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CCCCOC(=O)C1=C(C=CC(=C1)CC2=CC=C(C=C2)N)N",
    "object_id": "",
    "context": "Benzoic acid, 2-amino-5-[(4-aminophenyl)methyl]-, butyl ester is canonical SMILES. CCCCOC(=O)C1=C(C(C1)CC2=CC(C2)N)N.",
    "propertyCQ": "What is Benzoic acid?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27272042$0C928071-F210-4EEE-8307-0EC6917F8757",
    "theme": "ChemicalCompound",
    "subject_label": "pd-0210293",
    "subject_id": "Q27272042",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CCN(CC)CCCCNC1=NC2=CC(=C(C=C2N=C1C3=CC4=CC=CC=C4O3)Cl)Cl",
    "object_id": "",
    "context": "Pd-0210293 canonical SMILES is CCN(CC)CCCCNC1=NC2=CC(=C(C2N=C1C3=CC4=CC=CC=C4O3)Cl)Cl.",
    "propertyCQ": "",
    "objectCQ": "What is the Pd-0210293 canonical SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27198379$981E1621-0EB6-4175-8EE8-B0FA3E4B1AD9",
    "theme": "ChemicalCompound",
    "subject_label": "2-methoxy-N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide",
    "subject_id": "Q27198379",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CC1CN(C(COC2=C(C=C(C=C2)NC(=O)COC)C(=O)N(CC1OC)C)C)C(=O)COC",
    "object_id": "",
    "context": "2-methoxy-N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide is canonical SMILES.",
    "propertyCQ": "What is 2-methoxy-N-acetamide?",
    "objectCQ": "What is the canonical SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q83062707$CC403DD4-4E26-4DEC-8DFA-02E7A9F622BC",
    "theme": "ChemicalCompound",
    "subject_label": "Hpr 611",
    "subject_id": "Q83062707",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "C1CN(CCC1O)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O",
    "object_id": "",
    "context": "Hpr 611 canonical SMILES is C1CN(CCC1O)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O.",
    "propertyCQ": "",
    "objectCQ": "What is the Hpr 611 canonical SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27172050$2894B91E-EA87-412F-AE20-6F0D33C712BC",
    "theme": "ChemicalCompound",
    "subject_label": "(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-14-(2,2,2-trifluoroethylsulfonylamino)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide",
    "subject_id": "Q27172050",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CC1CN(C(COC2=C(C=C(C=C2)NS(=O)(=O)CC(F)(F)F)C(=O)N(CC1OC)C)C)C(=O)NC(C)C",
    "object_id": "",
    "context": "(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-N-propan-2-yl-14-(2,2,2-trifluoroethylsulfonylamino)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-triene-5-carboxamide are canonical SMILES.",
    "propertyCQ": "",
    "objectCQ": "What is the name of the canonical SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82029749$55F09662-4763-4007-9A44-CBAE024D4542",
    "theme": "ChemicalCompound",
    "subject_label": "5-bromo-3-methylpyrimidine-2,4(1h,3h)-dione",
    "subject_id": "Q82029749",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CN1C(=O)C(=CNC1=O)Br",
    "object_id": "",
    "context": "5-bromo-3-methylpyrimidine-2,4(1h,3h)-dione is canonical SMILES and is CN1C(=O)C(=CNC1=O)Br.",
    "propertyCQ": "",
    "objectCQ": "What is the canonical SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82438510$E9364268-DB92-4C5C-8A31-954F1A1C0442",
    "theme": "ChemicalCompound",
    "subject_label": "1,3,11,12-Tetrahydroxy-6-methyltetracene-2-carboxamide",
    "subject_id": "Q82438510",
    "property_label": "canonical SMILES",
    "property_id": "P233",
    "object_label": "CC1=C2C=C3C=C(C(=C(C3=C(C2=C(C4=CC=CC=C14)O)O)O)C(=O)N)O",
    "object_id": "",
    "context": "1,3,11,12-Tetrahydroxy-6-methyltetracene-2-carboxamide is canonical SMILES. CC1=C2C=C3C=C(C(C2=C(C4=CC=C14)O)O)C(=O)N)O.",
    "propertyCQ": "",
    "objectCQ": "What is the canonical SMILES?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q81996438$2F1CB2AD-8C9E-4514-8FBF-036F3D91A8DC",
    "theme": "ChemicalCompound",
    "subject_label": "Isodecyl tridecyl phthalate",
    "subject_id": "Q81996438",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₃₁H₅₂O₄",
    "object_id": "",
    "context": "Isodecyl tridecyl phthalate has a chemical formula of C31H52O4.",
    "propertyCQ": "What is C31H52O4?",
    "objectCQ": "What is the chemical formula of isodecyl tridecyl phthalate?",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q76736884$E3717136-C6A6-42A7-9E55-8E8809B64FD8",
    "theme": "ChemicalCompound",
    "subject_label": "[(2S)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-docos-11-enoate",
    "subject_id": "Q76736884",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₅₇H₁₀₀O₆",
    "object_id": "",
    "context": "The chemical formula for [(2S)-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropyl] (Z)-docos-11-enoate is C57H100O6.",
    "propertyCQ": "What is C57H100O6?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q105149120$844434DD-94B0-4CF1-AA34-3BB87F49CCE5",
    "theme": "ChemicalCompound",
    "subject_label": "4-hydroxy-6-(prop-1-en-1-yl)pyran-2-one",
    "subject_id": "Q105149120",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₈H₈O₃",
    "object_id": "",
    "context": "4-hydroxy-6-(prop-1-en-1-yl)pyran-2-one has the chemical formula of C8H8O3.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82033032$1D911972-D997-4810-B90D-DC5C5E40BBEC",
    "theme": "ChemicalCompound",
    "subject_label": "2,4-difluoro-N-(2-nitrophenyl)aniline",
    "subject_id": "Q82033032",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₂H₈F₂N₂O₂",
    "object_id": "",
    "context": "2,4-difluoro-N-(2-nitrophenyl)aniline has the chemical formula C12H8F2N2O2.",
    "propertyCQ": "What is C12H8F2N2O2?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q27458647$C048CEE3-E006-4154-9C9D-852FA8FE8402",
    "theme": "ChemicalCompound",
    "subject_label": "2'-deoxy-4'-thiocytidine 5'-(dihydrogen phosphate)",
    "subject_id": "Q27458647",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₉H₁₄N₃O₆PS",
    "object_id": "",
    "context": "2'-deoxy-4'-thiocytidine 5'-(dihydrogen phosphate) has the chemical formula C9H14N3O6PS.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82391573$047E3A3C-2F88-47E4-9468-995497DA5AE0",
    "theme": "ChemicalCompound",
    "subject_label": "[Bis(trimethylsilyl)methylidene](phenylethynyl)phosphane",
    "subject_id": "Q82391573",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₅H₂₃PSi₂",
    "object_id": "",
    "context": "The chemical formula for [Bis(trimethylsilyl)methylidene](phenylethynyl)phosphane is C15H23PSi2.",
    "propertyCQ": "What is C15H23PSi2?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q90561578$EC9B82D3-B375-4A6A-B673-F2A535ABA94C",
    "theme": "ChemicalCompound",
    "subject_label": "Tricyclo[3.3.1.13,7]decan-1-amine, N-[1-(4-methoxyphenyl)ethyl]-",
    "subject_id": "Q90561578",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₉H₂₇NO",
    "object_id": "",
    "context": "Tricyclo[3.3.1.13,7]decan-1-amine, N-[1-(4-methoxyphenyl)ethyl]- has the chemical formula C19H27NO.",
    "propertyCQ": "What is C19H27NO?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82552122$C7119930-4E8A-41C9-9CA8-0B5C9B4B3128",
    "theme": "ChemicalCompound",
    "subject_label": "4-(2-Bromobenzoyl)benzonitrile",
    "subject_id": "Q82552122",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₄H₈BrNO",
    "object_id": "",
    "context": "4-(2-Bromobenzoyl)benzonitrile has the chemical formula C14H8BrNO.",
    "propertyCQ": "What is C14H8BrNO?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82599848$310C564A-7913-4CE8-82D1-0CBB1CB4F606",
    "theme": "ChemicalCompound",
    "subject_label": "5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline",
    "subject_id": "Q82599848",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₂H₁₇BFNO₂",
    "object_id": "",
    "context": "5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline has the chemical formula C12H17BFNO2.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82611504$70832C0C-CBB2-45E6-BE01-0D8E02DBD829",
    "theme": "ChemicalCompound",
    "subject_label": "3',4'-Difluoro-5-methoxy[1,1'-biphenyl]-3-ol",
    "subject_id": "Q82611504",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₃H₁₀F₂O₂",
    "object_id": "",
    "context": "3',4'-Difluoro-5-methoxy[1,1'-biphenyl]-3-ol has the chemical formula C13H10F2O2.",
    "propertyCQ": "",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  },
  {
    "claim_id": "Q82689773$C01BBE34-1A45-4D8A-9E57-E3194915BFEE",
    "theme": "ChemicalCompound",
    "subject_label": "Methyl 5-(piperazin-1-yl)pentanoate",
    "subject_id": "Q82689773",
    "property_label": "chemical formula",
    "property_id": "P274",
    "object_label": "C₁₀H₂₀N₂O₂",
    "object_id": "",
    "context": "Methyl 5-(piperazin-1-yl)pentanoate has the chemical formula C10H20N2O2.",
    "propertyCQ": "What is C10H20N2O2?",
    "objectCQ": "",
    "generalizedPropertyCQ": "",
    "generalizedObjectCQ": ""
  }
]
